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Abstract 
Detoxification of aflatoxin B1 and T-2 
by probiotic yoghurt bacteria 
 
by 
Walter Odhiambo Ondiek 
 
Certain strains of lactic acid bacteria (LAB) have been shown to be able to detoxify some mycotoxins. 
Different LAB species such as Lactobacillus casei and L. acidophilus are used as probiotics in several 
products including yoghurt, cheese, buttermilk, and frozen desserts. Limited work has been done to 
isolate LAB from foods such as probiotic-enriched yoghurts or fermented dairy foods to assess their 
ability to detoxify aflatoxin B1 (AFB1) and trichothecene-2 toxin (T-2). The objectives of this project 
were to (1) isolate L. casei shirota from a fermented milk drink (FMD) and L. acidophilus, L. bulgaricus 
and Streptococcus thermophilus from a conventional yoghurt (CY), (2) determine the viability of these 
LAB species when incubated with AFB1 (5, 10, 20, 50 and 100 µg/L) and T-2 (20, 50, 100, 200 and 250 
µg/L), (3) determine the capacity of these LAB species (109 cells/mL) to detoxify AFB1 and T-2, and (4) 
compare the detoxification rate between live (non-heat-treated) and denatured (heat-treated) cells of 
L. casei shirota. A pure commercial L. acidophilus AS1.3342 culture was used as a positive control. L. 
acidophilus AS1.3342 and the food-derived L. casei shirota were used singly whereas L. acidophilus, L. 
bulgaricus and Streptococcus thermophilus isolated from CY were used as a mixture. All bacteria were 
able to detoxify AFB1 and T-2 but there were no significant differences between the bacteria in their 
capacity to detoxify the toxins. The toxin removed [both in absolute quantity (µg/L) and as a 
percentage] by live cells significantly increased as the toxin concentration increased in spite of the 
bacterial cell viability declining with exposure to increase in toxin concentrations. Live cells of L. casei 
shirota detoxified 11–43% of AFB1, 19–38% of T-2; L. acidophilus AS1.3342, 10–46% AFB1 and 15–45% 
T-2; and the mixture of live CY strains, 14–43% AFB1 and 15–45% T-2. The absolute quantity of toxin 
removed by denatured cells also significantly increased with increase in toxin concentration. Expressed 
as a percentage, denatured cells detoxified more of the toxins (L. casei shirota detoxified 48–62% AFB1 
 iii
and 42–53% T-2) compared with exposure to live bacterial cells, lending support to the hypothesis that 
denatured bacterial cells are able to remove more toxins than live cells possibly due to the higher 
binding of toxins to the cell membrane of non-viable cells. These findings show that bacteria in 
probiotic milk foods, irrespective of whether live or denatured, can bind significant amounts of AFB1 
and T-2, especially when exposed to higher toxin concentrations, and thereby markedly reduce 
exposure of consumers to these mycotoxins. 
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1
Chapter 1 
Introduction 
Mycotoxins are secondary metabolites of fungi and are commonly found in agricultural produce. They 
can cause teratogenicity, carcinogenicity, and oestrogenic or immune-suppressive effects in animals 
and humans, and overall economic loss (Bhat, Rai, & Karim, 2010; Lahtinen, Haskard, Ouwehand, 
Salminen, & Ahokas, 2004; Woloshuk & Shim, 2013). Major mycotoxins include aflatoxins, 
deoxynivalenol, fumonisins, zearalenone, T-2, ochratoxin and certain ergot alkaloids (Richard, 2007). 
Aflatoxins are produced by Aspergillus flavus and A. parasiticus while T-2 is produced by Fusarium 
graminearum and related species. These toxigenic fungi are ubiquitous in nature and can occur at pre-
harvest, at harvest or can grow saprophytically on plants and stored agricultural products (Binder, Tan, 
Chin, Handl, & Richard, 2007; Jouany, 2007). The most susceptible products include cereals, peanuts, 
figs, peas, sunflower seeds, sesame seeds, pistachios, and almonds (Logrieco, Bottalico, Mulé, Moretti, 
& Perrone, 2003). Aflatoxin contamination tends to predominate in the tropical and subtropical 
countries (Pitt, 2000), but can also grow in the temperate regions of America, Europe and Asia, with 
Fusarium fungi identified as the most prevalent toxin-producing fungi commonly found on cereals such 
as oats (Creppy, 2002). Both aflatoxin and T-2 can directly or indirectly lead to human toxicity. Direct 
intoxication occurs when the contaminated foods are ingested by humans, while indirect intoxication 
can arise from mycotoxin residues in animal products as a result of usage of contaminated livestock 
feed (Zain, 2011). 
Several types of aflatoxins have been identified. However, the main naturally produced aflatoxins with 
economic and health impacts include aflatoxin B1, B2, G1, and G2 (Yang et al., 2014). Among the group, 
AFB1 is listed as a Group 1 carcinogen and is the most important due to significantly increased risk of 
hepatocellular carcinoma in humans exposed to AFB1 (International Agency for Research on Cancer, 
2002). T-2 causes a variety of toxic effects in experimental animals and livestock and is also known to 
cause toxic effects in human. The major effects of T-2 include inhibition of protein synthesis in several 
cellular systems, followed by secondary disruption to DNA and RNA synthesis (Chen et al., 2008; Zou 
et al., 2012). T-2 has been shown to inhibit synthesis of DNA (at exposure to 750 μg/kg body weight 
single or multiple doses) and RNA (at doses > 100-1000 μg/mL) in both in vivo and in vitro tests (EU, 
2001). 
According to Codex Alimentarius (2014), strategies for the reduction of mycotoxins in cereals consist 
of two approaches, namely, recommended practices based on Good Agricultural Practice (GAP) and 
Good Manufacturing Practice (GMP) while Hazard Analysis Critical Control Point principles are applied 
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as a complementary management system. In addition to Codex recommendations, institutionalisation 
of mycotoxin regulations has been adopted to manage mycotoxins in the food chain. By the end of 
2003, around 100 countries (covering approximately 85% of the world’s inhabitants) had specific 
regulations or detailed guidelines for limiting mycotoxins in food (van Egmond, Schothorst, & Jonker, 
2007). Despite the Codex recommendations and institutionalisation of mycotoxin regulations, it is still 
not possible to totally preclude mycotoxin contamination. This is because the toxigenic fungi are 
ubiquitous in nature and most critical factors for mycotoxin production are extrinsic in nature and as 
such there are continued reports of incidences of mycotoxin contamination in various food 
commodities, particularly in the tropics and subtropics where high ambient humidity makes the control 
of commodity moisture difficult (Codex Alimentarius, 2014; Matumba, Van Poucke, Ediage, & De 
Saeger, 2015). Additionally, institutionalisation of mycotoxin regulation has not been successful due 
to the high prevalence of informal markets, especially in developing countries. According to ICRISAT, 
Ananth, and Farid (2015), aflatoxin poisoning in humans has been reported in several countries 
including India, China, and several African countries. For example, in a case study involving 3180 human 
immunodeficiency virus-negative specimens to quantify aflatoxin exposure across Kenya, serum AFB1-
lysine was detected in 78% of the samples (Yard et al., 2013). So, it appears that aflatoxin exposure is 
a public health problem throughout Kenya and this is probably true for many African countries. In 
China, a case study by Wang et al. (2001) on hepatocellular carcinoma and aflatoxin exposure, in 
Zhuqing Village of Fusui County, detected a considerable amount of AFB1-albumin adducts in the 
serum, and in 88.9% of the subjects, AFB1 metabolites were observed in the urine. According to the EU 
(2003), T-2 is a common contaminant in cereal samples from EU member states, and therefore EU 
member populations were at risk of dietary exposure to Fusarium toxins including T-2, and the most 
frequently contaminated cereal samples were corn (28 %), wheat (21 %) and oat (21 %). In its 2013 
review, the EU Commission, through the scientific panel on contaminants in the food chain of the 
European Food Safety Authority (EFSA), indicated that estimates of chronic human dietary exposure 
to the sum of T-2 and HT-2 (a metabolite of T-2) were below the tolerable daily intake for populations 
of all age groups, and thus not an immediate health concern. However, the Commission acknowledged 
that there was large year-to-year variation in occurrence of T-2 and HT-2 in cereals (EU, 2013). 
In order to decontaminate mycotoxin-contaminated food or feed, and minimise exposure to 
mycotoxins and reduce health risks, physical, chemical and biological methods have been used. 
Physical methods such as sorting, trimming, cleaning, milling, cooking, canning, flaking, and extrusion 
have been established to reduce mycotoxin concentrations but these methods do not eliminate them 
completely and hence can lead to a potential mycotoxin contamination of processed foods (Bullerman 
& Bianchini, 2007). Chemical means include use of alkaline compounds such as ammonia to detoxify 
the mycotoxins. Chemical treatments reduce mycotoxin concentration significantly but many of these 
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chemicals are toxic and also cause a loss of some nutrients (Bata & Lasztity, 1999). Owing to these 
limitations, biological methods have been pursued as the most promising safe option for 
decontamination of mycotoxin-contaminated food and feed (Bata & Lasztity, 1999; Kabak, Dobson, & 
Var, 2006). It was reported that binding of mycotoxins by LAB from fermented foods and by LAB 
present in the gastrointestinal tract could contribute to a decrease in toxin bioavailability (Niderkorn, 
Morgavi, Aboab, Lemaire, & Boudra, 2009). 
Despite the great potential benefits that LAB may hold towards reducing human exposure to 
mycotoxins, only a handful of work has been done on isolation of LAB from probiotic foods to assess 
their ability to detoxify various concentrations of AFB1 and T-2. 
1.1 Aims and objectives 
The major aim of this project was to determine if bacteria isolated from  probiotic-enriched yoghurt 
(L. casei shirota from fermented milk drink (FMD) and L. acidophilus, L. bulgaricus and Streptococcus 
thermophilus from yoghurt (CY)) are capable of detoxifying AFB1 and T-2. A secondary aim was to 
provide data from this experiment as a reference for use of probiotic-enriched foods, such as yoghurt, 
in future clinical trials to remove mycotoxins from the human digestive system. 
 
The objectives of this project were to: 
(1) Isolate L. casei shirota from FMD yoghurt and L. acidophilus, L. bulgaricus and 
Streptococcus thermophilus from CY yoghurt 
(2) Determine the capacity of these LAB species (109 cells/mL) to detoxify various concentrations of 
AFB1 (5, 10, 20, 50 and 100 µg/L) and T-2 (20, 50, 100, 200 and 250 µg/L) 
(3) Compare the detoxification rate between live and denatured cells of L. casei shirota 
(4) Determine the viability of LAB species when incubated with AFB1 (5, 10, 20, 50 and 100 µg/L) and 
T-2 (20, 50, 100, 200 and 250 µg/L). 
1.2 Research hypotheses 
i. LAB (L. casei shirota, L. acidophilus, L. bulgaricus and Streptococcus thermophilus) 
isolated from probiotic-enriched yoghurts will detoxify AFB1 
ii. LAB (L. casei shirota, L. acidophilus, L. bulgaricus and Streptococcus thermophilus) 
isolated from probiotic-enriched yoghurts will detoxify T-2. 
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1.3 Study approach 
This research was conducted at Guangdong Ocean University (GDOU), China; courtesy of research 
collaboration between the College of Food Science & Technology, Guangdong Ocean University, China, 
and the Department of Wine, Food & Molecular Biosciences of Lincoln University, New Zealand. The 
research objectives, aims, hypothesis, and methodology were developed in accordance with the house 
rules for the study of Masters at Lincoln University (Lincoln University, 2016). The input of the external 
advisers (College of Food Science & Technology, Guangdong Ocean University, China) was also taken 
into consideration. Prior to commencement of the study, the proposal was presented as a seminar to 
the Faculty of Agricultural and Life Sciences, Lincoln University, and also the College of Food Sciences, 
GDOU, attended by both staff and postgraduate students. Suggestions that came out of these two 
seminars and the discussions with the supervisors were taken into consideration before the final draft 
was written and submitted for approval by the Research Committee of the Faculty of Agriculture and 
Life Sciences, Lincoln University. Potential health and safety hazards that may arise during 
experimentation were identified and appropriate control measures were taken to manage the hazards 
prior to the commencement of the research (Table A1). Thesis writing was done in accordance with 
the house rules for the study of Masters at Lincoln University (Lincoln University, 2016). 
The research involved three crucial phases: sampling and isolation of the bacteria, toxin extraction, 
and toxin assay. The first two phases (LAB isolation and toxin extraction) were conducted in the 
laboratories of the College of Food Science & Technology, Guangdong Ocean University, China. 
Isolation of LAB was done in the Food Microbiology laboratory while toxin extraction was performed 
in the Toxicology laboratory at GDOU University (Figs C1–C11). The last phase (toxin assay) was 
conducted at the National Marine Products Quality Supervision & Inspection Centre, Zhanjiang, China. 
1.4 Chapter outline 
This thesis has six chapters: Introduction, Literature Review, Materials and Methods, Results, 
Discussion and Conclusion. 
Chapter 1 gives an introduction to the project, which covers an overview of the thesis and problem 
statement, aims and objectives, research hypothesis, and study approach and study area context. 
In Chapter 2, a detailed literature review is presented to provide the reader with an in-depth 
understanding of the subject. The literature review covered a variety of topics including definitions, 
ecology and major groups of mycotoxins, aflatoxins and trichothecene toxins including T-2, aflatoxin 
toxicoses, T-2 toxicoses, aflatoxin and T-2 metabolism, and prevention and control of aflatoxin and T-
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2 contamination. It also covered LAB, their characteristics and usage in food, recent studies on the use 
of LAB to detoxify mycotoxins and mode of mycotoxin removal by the bacteria. 
Chapter 3 describes materials and methods. Materials, chemicals and all reagents that were used in 
this research such as samples, media, chemicals and toxins are identified. It also covers methodology 
such as isolation and identification of LAB, preparation of LAB working cultures, preparation of AFB1 
and T-2 standard solutions, toxin extraction and assay of the toxins. This chapter also describes the 
protocol for viability testing. Finally, the chapter highlights the methodology for data analysis, the 
software used to conduct statistical analysis, and the form in which the analytical results are presented. 
Chapter 4 presents the results. The quantities of AFB1 and T-2 detoxified by the bacteria are presented 
as absolute amount and percentages in a graphical format and also summarised in text. The bacterial 
viability results are presented in a table format and summarised in text. 
In Chapter 5, the results are discussed, interpreted and compared with previous findings. The 
significance of the data and the new knowledge generated from this study is presented here. 
Chapter 6 presents the conclusion. This chapter summarises key points including the performance of 
food-isolated probiotic bacteria in detoxifying AFB1 and T-2. Finally, a suggestion is made on how the 
research findings could be used in the future. 
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Chapter 2 
Literature Review 
2.1 Definition, major groups of mycotoxins and ecology 
The term mycotoxin has been defined in the literature in a variety of ways. For example, FAO (2016, p. 
1) defines mycotoxins as ‘’toxic secondary metabolites of fungi belonging, essentially, to the 
Aspergillus, Penicillium and Fusarium genera’’. Diaz, Whitlow, and Hagler (2013) define a mycotoxin as 
a fungal metabolite that causes an undesirable effect when animals or humans are exposed through 
consumption of contaminated feedstuffs/foods or through airborne exposure. The US Food and Drug 
Administration Office of Regulatory Affairs (2013) defines mycotoxins as natural poisons produced by 
fungi as secondary metabolites, which can occur in food due to mould growth during harvest or 
storage. Mycotoxins have also been defined as natural products of fungi, which cause toxic effects to 
higher vertebrates and other animals in low concentration when introduced through natural routes 
(Chelkowski, 2014). Despite the variation in definition, in principle, they all refer to mycotoxins as 
secondary metabolites produced by fungi and that these secondary metabolites have potential to 
cause toxic effects to humans and animals to a certain degree when consumed (Taevernier, 
Wynendaele, De Vreese, Burvenich, & De Spiegeleer, 2016). 
The predominant toxigenic fungal flora include the following genera: Aspergillus, Fusarium, and 
Penicillium species (Kabak et al., 2006). These toxigenic fungi are ubiquitous in nature and can occur 
at pre-harvest, during harvesting or can grow saprophytically on plants and stored agricultural 
products such as cereals, nuts, coffee, cocoa, oilseeds, grapes, wines and vine fruits, barley, dried peas 
and beans (Jouany, 2007; Logrieco et al., 2003). Growth of toxigenic fungi in agricultural produce can 
result in production loss and hence economic losses, as well as production of mycotoxins, with possible 
development of mostly chronic effects in animals and humans when consumed. Chronic effects may 
include teratogenic, carcinogenic, oestrogenic or immune-suppressive effects and sometimes death 
(Binder et al., 2007). Mycotoxin contamination can lead to food poisoning by direct ingestion of 
contaminated food by humans or indirectly by ingestion of mycotoxin residues in animal products as 
a result of usage of contaminated livestock feed (Zain, 2011). Aspergillus, Fusarium and Penicillium are 
responsible for the production of five major kinds of mycotoxins: aflatoxins, fumonisins, ochratoxin, 
zearalenone (ZEN) and trichothecenes including T-2 and deoxynivalenol (DON) (Murphy, Hendrich, 
Landgren, & Bryant, 2006; Richard, 2007). Aflatoxins are produced by Aspergillus flavus and 
A.  parasiticus, while trichothecenes are produced by Fusarium graminearum and related species (Pitt, 
2000). However, aflatoxin contamination tends to predominate in tropical and subtropical countries – 
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areas with a hot and humid climate that are favourable for the growth of moulds – than in temperate 
regions (Pitt, 2000). In the temperate regions of America, Europe and Asia, Fusarium has been 
identified as the most prevalent toxin-producing fungi because it can tolerate lower temperatures than 
Aspergillus fungi (Creppy, 2002) and are commonly found on cereals. 
Toxigenic fungi are known to grow over a wide range of pH (between 4 and 8), temperature (between 
10 and 40°C), and water activity (aw; usually at levels above 0.70) (Bhat et al., 2010). However, 
interactions of several factors influence the nature and quantity of mycotoxins produced by fungi. 
These factors include nutritional composition of substrate, moisture content, temperature, humidity 
in the surrounding environment, maturity of the fungal colony, co-occurrence with other fungi, 
competition from other microorganisms, stress factors, physical damage of the substrate due to insect 
activity, and other associated factors (Abbas, Valez, & Dobson, 2009; Bhat et al., 2010). According to 
FAO (2008), some of these factors, particularly those related to climatic change such as increase in 
global temperature and humidity, could have a major impact on fungal ecology and growth, 
persistence and patterns of occurrence and changes in the incidence and intensity of plant and pest 
infestations in the near future, and all these factors could impact on mycotoxin production. Aflatoxin 
and trichothecene contamination of agricultural staples such as wheat, barley and maize during fungal 
colonisation is an increasingly common problem possibly because of expanded use of ‘no-till farming’ 
and changing climatic patterns. Since food and feed contamination by aflatoxins and trichothecenes 
has been associated with human and animal toxicoses, serious questions remain to be answered 
regarding assessment of potential risks from ingesting-food borne aflatoxins and trichothecenes, and 
how these should be regulated and degraded or detoxified. 
2.2 Aflatoxins 
Several types of aflatoxins have been identified. However, the main naturally produced aflatoxins of 
economic and health impact include aflatoxin B1, B2, G1, and G2 (Yang et al., 2014). Aflatoxins B1 (AFB1) 
and B2 are produced by Aspergillus flavus and A. parasiticus while aflatoxins G1 and G2 are produced by 
A. parasiticus (Gnonlonfin et al., 2013). ‘B’ and ‘G’ refer to the blue and green fluorescent colours 
produced by these compounds under UV light on thin layer chromatography plates, whereas the 
subscript numbers 1 and 2 indicate major and minor compounds (Bennett & Klich, 2003; Sweeney & 
Dobson, 1998). Fig. 1 shows the molecular structure of AFB1. 
Toxicity caused by consumption of aflatoxin-contaminated food is called aflatoxicosis, which can occur 
as acute and/or chronic toxicity in both humans and animals (Li, Yoshizawa, Kawamura, Luo, & Li, 
2001). Aflatoxin-induced acute toxicity is often characterised by exposure to high doses over a short 
period and has a rapid onset and toxic effect including sudden death (Nyikal et al., 2004). Chronic 
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toxicity is more common and is characterised by low-dose exposure over a long period, which can 
generally result in long-term irreversible effects including cancer (Bennett & Klich, 2003). According to 
the International Agency for Research on Cancer (2002) , evaluation of previous studies of 
carcinogenicity of aflatoxins in experimental animals showed that there was strong evidence for AFB1-
induced carcinogenicity in animals. Oral administration of aflatoxin mixtures and AFB1 to several strains 
of rats, hamsters, salmon, trout, ducks, tree shrews and monkeys was found to induce benign and 
malignant hepatocellular tumours. Specifically, Wogan, Edwards, and Newberne (1971) showed that 
AFB1 dosed by stomach tube to rats at 1.5 mg/rat, given 5 days a week for 8 weeks, induced 
hepatocellular carcinoma. Again, based on statistically and significantly increased risks for 
hepatocellular carcinoma in humans exposed to aflatoxins, AFB1 is now listed as a Group 1 carcinogen 
by the International Agency for Research on Cancer. In addition, the risk for hepatocellular carcinoma 
is elevated in areas where hepatitis B virus infection is endemic such as in the African continent (Lewis 
et al., 2005). 
 
Fig. 1: Structure of aflatoxin B1. Adapted from Richard (2007). 
 
2.3 T-2 
As many as 160 trichothecenes have been identified and are classified into four main groups according 
to their chemical structure, namely type A, B, C, and D (Bhat et al., 2010). One common feature among 
trichothecenes is the presence of a tetracyclic sesquiterpenoid 12,13-epoxytrichothec-9-ene ring (Fig. 
2), with the 12,13-epoxy ring being responsible for its toxicological activity (Li et al., 2011). Type A 
trichothecenes have a functional group other than a ketone at position C-8, Type B a ketone at position 
C-8, Type C a second epoxy group at C-7, 8 or C-9, 10, and Type D a macrocyclic ring between C-4 and 
C-5 with two ester linkages (Sweeney & Dobson, 1998). Major toxins under Type A trichothecenes are 
T-2 and HT-2 but T-2 is the most important because it is considered to be the most toxic among the 
trichothecenes (Zou et al., 2012). Fig. 2 shows the chemical structures of Type A trichothecene and 
several other trichothecenes (Types B, C & D). 
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T-2 and HT-2 are commonly found in cereal grains such as wheat, oats and maize as well as in animal 
feed and human foods produced from contaminated grains (He, Zhou, Young, Boland, & Scott, 2010) 
and these create a food safety risk. T-2 causes a variety of toxic effects in experimental animals, 
livestock and also humans. The major effects of T-2 toxin include inhibition of protein syntheses in 
several cellular systems, followed by secondary disruption of DNA and RNA synthesis (Chen et al., 2008; 
Zou et al., 2012). Specifically, in both in vivo and in vitro tests, T-2 toxin has been shown to inhibit 
synthesis of DNA (at exposure to 750 μg/kg body weight single or multiple doses) and RNA (at exposure 
doses > 100–1000 μg/mL) (EU, 2001). Other toxic effects include vomiting, diarrhoea, lethargy, weight 
loss, anorexia, haemorrhage, immune-suppression, induction of apoptosis and necrosis of the 
epithelium of stomach and intestine, bone marrow, spleen, testis and ovary (EU, 2003; Li et al., 2011). 
 
Fig. 2: Structures of type A trichothecenes (T-2 and HT-2 toxins) and other trichothecenes (types B, 
C, and D). Adapted from Li et al. (2011). 
2.4 Aflatoxin B1 toxicoses 
AFB1 contamination has been reported in many countries, especially in tropical and subtropical regions 
where conditions of temperature and humidity are conducive for maximal fungal growth and 
subsequent toxin production. According to ICRISAT et al. (2015), aflatoxin poisoning in human has been 
reported in several countries including India, China, and several African countries. For example, in April 
2004, an acute outbreak of aflatoxin contamination of locally grown maize occurred in Eastern and 
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Central regions of Kenya, which resulted in 317 reported cases and 125 deaths (Nyikal et al., 2004). 
Following the outbreak, a cross-sectional survey was conducted by Lewis et al. (2005) to assess the 
extent of market maize contamination and to evaluate the relationship between market maize 
aflatoxin and the aflatoxicosis outbreak. It was established that 55% of maize products had aflatoxin 
levels greater than the Kenyan regulatory limit of 20 μg/kg, 35% had levels > 100 μg/kg, and 7% had 
levels > 1,000 μg/kg. In another case study to quantify aflatoxin exposure across Kenya, among 3180 
immunodeficiency virus-negative subjects, AFB1-lysine was detected in 78% of 600 serum specimen 
(Yard et al., 2013). The study showed that aflatoxin exposure was a public health problem throughout 
Kenya, which could impact human health and this is probably true for many African countries. In China, 
a case study by Wang et al. (2001) on hepatocellular carcinoma and aflatoxin exposure in Zhuqing 
Village, Fusui County, a considerable amount of AFB1-albumin adducts in the serum and AFB1 
metabolites were observed in the urine of 88.9% of the subjects. Similarly, in Guangxi Province of 
China, a comparative study on the natural occurrence of aflatoxins and Fusarium toxins was conducted 
with corn samples in high- and low-incidence areas of human primary hepatocellular carcinoma (Li et 
al., 2001). Results showed that AFB1 was the predominant toxin detected in terms of quantity and 
frequency. The study also reported that 13 samples (76%) exceeded the Chinese regulation of 20 μg/kg 
for AFB1 in corn and corn-based products intended for human consumption. In India, Reddy, Reddy, 
and Muralidharan (2009) detected Aspergillus spp. and AFB1 in rice from 20 states and reported that 
out of 1200 samples, 2% showed AFB1 contamination above the Indian permissible limit of 30 μg/kg. 
2.5 T-2 toxicoses 
Contamination of cereal by T-2 and HT-2 is widely reported in the scientific literature. A study by Kassim 
et al. (2011) on T-2 and HT-2 in cereals sold in traditional markets in Gyeongnam Province of South 
Korea revealed that out of 75 samples analysed, 13 and 25 samples were found to be contaminated 
with T-2 (35.2–431.0 μg/kg) and HT-2 toxins (21.1–442.7 μg/kg) respectively and four samples were 
found to be contaminated with both toxins. In a survey by Pettersson et al. (2011) on T-2 and HT-2 in 
oats and oat products from European oat mills (UK, Finland, Ireland, Poland and Germany), the mean 
values of T-2  and HT-2 were 94, 17, 11 and 293 µg/kg in oats, oat flakes, oat meal and oat by-products 
respectively. However, it was established that during processing, the toxins were reduced by 82–88%. 
However, in the same survey, a significant increment of T-2 was observed in oat by-products. Hussein, 
Franich, Baxter, and Andrew (1989) investigating naturally occurring Fusarium toxins in New Zealand 
maize concluded that T-2, DON, diacetoxyscirpenol, and ZEN mycotoxins were prevalent in healthy 
standing crops as well as in stored maize. Some of these readings were significantly above the 
maximum tolerated limit for T-2 toxin (100 μg/kg) that has been set by a majority of countries (FAO, 
2004). 
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According to the EU (2003), T-2 is a common contaminant in cereal samples from EU member states, 
and therefore EU member populations were at risk of dietary exposure, and the most frequently 
contaminated cereal samples were corn (28%), wheat (21%) and oats (21%). In its 2013 review, the EU 
Commission, through the scientific panel on contaminants in the food chain of the European Food 
Safety Authority (EFSA), indicated that estimates of chronic human dietary exposure of the EU 
community to the sum of T-2 and HT-2 was below the tolerable daily intake for populations of all age 
groups, and thus was not regarded as an immediate health concern. However, the EU Commission 
acknowledged that there was a large year-to-year variation in cereal T-2 and HT-2 concentrations (EU, 
2013). 
2.6 Metabolism of AFB1 and T-2 
The AFB1 molecule is transported across the plasma membrane and is bio-transformed by microsomal 
mixed function monooxygenases to form highly reactive AFB1-8-9- epoxide (Kirby et al., 1993). Bio-
activated epoxide binds to nuclear DNA, causing nuclear damage, hepatotoxicity and carcinogenicity 
(Daniels, Liu, Stewart, & Massey, 1990). In vivo detoxification of AFB1 can take place through 
conjugation of the reactive epoxide to glutathione (GSH). When Degen and Neumann (1978) injected 
AFB1 into female Wistar rats, half of the dose was eliminated in bile as polar non-extractable 
metabolites. The main component of the metabolite was a GSH conjugate; identified as 2,3-dihydro-
2-(S-glutathionyl)-3-hydroxy aflatoxin B1 (AFB1-GSH-conjugate). These findings clearly show that in vivo 
detoxification of AFB1 involves conjugation of the reactive epoxide by GSH, which is excreted primarily 
through the bile. However, the amount of GSH in the liver is limited and also conjugate has the 
potential to be hydrolysed by the intestine microflora to release AFB1 for reabsorption. 
Another means of AFB1 detoxification is hydroxylation, through monooxygenase-mediated 
biotransformation pathways to hydroxylated metabolites such as aflatoxin M1 and aflatoxin Q1 (Daniels 
et al., 1990). When AFB1  is ingested by humans or animals, a small proportion is hydroxylated via phase 
I biotransformation into aflatoxins M1 albeit with lower toxicity than the parent molecules (El-Nezami, 
Nicoletti, Neal, Donohue, & Ahokas, 1995). 
Several studies, both in vitro and in vivo, have improved our understanding of T-2 biotransformation. 
Ohta, Ishii, and Ueno (1977) conducted a study to elucidate the active form of T-2 during tissue 
metabolism. It was apparent that T-2 was selectively hydrolysed by the microsomal esterase at C-4, 
giving rise to HT-2 as the only metabolite. The authors concluded that toxicity of T-2 administered to 
animals is also partly due to the metabolite HT-2. This was presumed because the toxicity of HT-2 is 
comparable to that of T-2 and that the microsomal fraction of liver possesses the capability to bio-
transform the total T-2 dose to HT-2 within a few minutes. Additionally, an in vivo study by Visconti 
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and Mirocha (1985) on identification of various T-2 metabolites in chicken excreta and tissues noted 
that the majority of the T-2 metabolites were detected in the excreta, although the amount detected 
in the liver was also adequate to cause tissue toxicity especially to the liver. T-2 was found in trace 
amounts in the lungs but not in the heart or kidney. They detected several metabolites of T-2, namely 
HT-2, 15 acetoxy T-2 tetraol, and T-2 tetraol, 3'-hydroxy HT-2, 3'-hydroxy T-2, 4-acetoxy T-2 tetraol, 
trace amounts of 8-acetoxy T-2 tetraol, 3-acetoxy-3'hydroxy HT-2, and T-2 triol. Metabolism and 
elimination of T-2 is generally rapid after ingestion, with major metabolic reactions being hydrolysis, 
hydroxylation, de-epoxidation, and conjugation (Li et al., 2011). 
2.7 Prevention and control of aflatoxins and T-2 
According to Codex Alimentarius (2014), strategies for the reduction of mycotoxins in cereals 
consist of two approaches, namely, recommended practices based on GAP and GMP while 
Hazard Analysis Critical Control Point principles are applied as a complementary management 
system. GAP represents the first line of defence against contamination of food commodities 
with mycotoxins in the field and includes pre-harvest selection of hybrids, choice of time of 
planting, plant density and insect control (Codex Alimentarius, 2014). This is supplemented by 
the implementation of GMP during the handling, storage, and distribution of the food 
commodities. GMP includes minimising time between harvesting and drying, effective 
cleaning of cereal prior to storage, efficient drying of wet cereals for medium- and long-term 
storage, effective hygiene and management in store, absence of pests in store (which can 
provide metabolic water and initiate heating), clear specifications and traceability from field 
to store (Magan & Aldred, 2007). In addition to Codex recommendations, institutionalisation 
of mycotoxin regulations has been adopted as a means of managing mycotoxins in the food 
chain. By the end of 2003, about 100 countries (with approximately 85% of the world’s 
inhabitants) had specific regulations or detailed guidelines for mycotoxins in food (van 
Egmond et al., 2007). 
Despite all these regulations and preventive measures on the farm, it is still not possible to 
totally preclude mycotoxin contamination of food and feed because the toxicogenic fungi are 
ubiquitous in nature and most critical factors for mycotoxin production are extrinsic in nature 
(Codex Alimentarius, 2014; Matumba et al., 2015). Additionally, institutionalisation of 
mycotoxin regulation has not been successful, more so in developing countries, due to high 
prevalence of informal markets. 
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In order to prevent mycotoxin-contamination of food and feed and thereby minimise 
exposure to mycotoxins and reduce health risks, physical, chemical and biological methods 
have been tried but with little success (Bata & Lasztity, 1999). According to Bullerman and 
Bianchini (2007), physical methods include sorting, trimming, cleaning, milling, cooking, 
canning, flaking, and extrusion. These processes lower mycotoxin concentrations but do not 
reduce them significantly. Chemical means include the use of alkaline compounds such as 
ammonia to detoxify. Chemical treatments reduce mycotoxin concentration significantly but 
these chemicals are toxic and also degrade some nutrients (Bata & Lasztity, 1999). Owing to 
these limitations, biological methods have been pursued as the most promising option for 
decontamination of mycotoxin-contaminated food and feed (Bata & Lasztity, 1999; Kabak et 
al., 2006). It has been claimed that binding of mycotoxins by LAB from fermented foods and 
by LAB present in the gastrointestinal tract could contribute to a reduction in the toxin 
bioavailability (Niderkorn et al., 2009). 
2.8 Lactic acid bacteria, characteristics and their use in food 
Lactic acid bacteria are a group of Gram-positive, acid-tolerant, non-sporing, non-motile, catalase 
negative bacteria, and are either rod- or cocci-shaped. These are strictly fermentative bacteria which 
convert carbohydrates to lactic acid as the major end product (Teuber, 1993). Besides lactic acid, some 
heterofermentative strains produce acetic acid, ethyl alcohol and carbon dioxide (König & Fröhlich, 
2009). Several genera of LAB have been identified and include species of the genera Carnobacterium, 
Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, Oenococcus, Pediococcus, Streptococcus, 
Tetragenococcus, Vagococcus and Weissella (Stiles & Holzapfel, 1997). The cell wall of LAB has a 
cytoplasmic lipid membrane with polysaccharides and lipoteichoic acids (teichoic acids and lipoids), 
and protein subunits including surface layer proteins, commonly known as S-layer proteins, and is 
sheathed by a thick multi-layered peptidoglycan (Delcour, Ferain, Deghorain, Palumbo, & Hols, 1999; 
Nishiyama, Sugiyama, & Mukai, 2016). Thus, peptidoglycan is the main component of the LAB wall. It 
consists of glycan chains that are made of alternating N-acetylglucosamine and N-acetylmuramic acid 
that are linked via β-1,4 bonds (Chapot-Chartier & Kulakauskas, 2014). The peptidoglycan layer helps 
the bacteria to maintain cell shape and integrity during growth and division and it also acts as the 
interface between the bacterium and its environment (Chapot-Chartier & Kulakauskas, 2014). 
According to Neuhaus and Baddiley (2003), teichoic acids are polymers of glycerol-phosphate or ribitol-
phosphate attached to glycosyl and d-alanyl ester residues. Teichoic acids together with peptidoglycan 
make up a polyanionic matrix that provides cation homeostasis, regulation of autolysins, trafficking of 
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ions, nutrients, proteins, antibiotics, and presentation of envelope proteins (Neuhaus & Baddiley, 
2003). 
The bacterial S-layer is made up of either proteins or glycoproteins, with the protein subunits forming 
the porous lattice, which completely covers the cell (Beveridge et al., 1997). The S-layer is thought to 
provide several functions to bacteria. However, some of the documented functions include cell 
adhesion, protection from feeding by protozoa or phagocytes, virulence factor, antigenicity, anchoring 
sites for hydrolytic exo-enzymes, receptors for phages and porin function (Beveridge et al., 1997). Fig. 
3 shows the structure of the lactic acid bacteria (Gram-positive) cell wall. 
 
Fig. 3: Cell wall structure of Gram-positive lactic acid bacteria. The cell wall consists of a thick, 
multilayered peptidoglycan layer decorated with lipoteichoic acid, teichoic acid, and proteins 
including S-layer proteins. Adapted from Nishiyama, Sugiyama, & Mukai (2016). 
Some of the LAB are of major economic importance to the food industry because they are widely used 
in food fermentation as natural preservatives and flavour enhancers in fermented foods such as milk, 
meats, vegetables and cereal products (Stiles & Holzapfel, 1997). Additionally, species of Bifidobacteria 
and Lactobacilli have been used as probiotics in various foods and are also found as a part of 
gastrointestinal microflora. 
According to FAO/WHO (2001, p. 2), probiotic refers to ‘live microorganisms which when administered 
in adequate amounts confer a health benefit to the host’. However, for microorganisms to be used as 
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a probiotic, they must meet the following criteria. They should (i) be generally recognised as safe 
(GRAS), (ii) be resistant to acid and bile salts in the gut and intestine, (iii) be capable of surviving passage 
through the digestive tract, and (iv) have the capability to adhere and proliferate in the gut (Lin, Hwang, 
Chen, & Tsen, 2006). Based on these characteristics, different species of Lactobacillus, such as L. casei 
and L. acidophilus, have been employed in the dairy industry as probiotics and incorporated in several 
products such as yoghurt, cheese, fermented milk drinks including buttermilk, and frozen desserts 
(Granato, Branco, Cruz, Faria, & Shah, 2010). Specifically, the L. casei shirota strain is used as a probiotic 
in a fermented milk drink (FMD) (Shah, 2007) while L. acidophilus has been used in conventional 
yoghurts. Recent studies, as elaborated on in sections 2.9.1 and 2.9.2, have demonstrated that a wide 
range of LAB strains can detoxify mycotoxins. 
2.9 Recent studies on the use of lactic acid bacteria to detoxify 
mycotoxins 
2.9.1 Aflatoxins 
A wide range of LAB strains have been shown to possess the ability to remove aflatoxins specially from 
milk based media. El-Nezami et al. (1998), in their research on the ability of dairy strains of LAB to bind 
common food carcinogens including AFB1, reported that binding was a rapid process because the 
percentage of AFB1 residue in a few minutes was not significantly different from that at 72 h. At 0 h, 
viable cells (1010 cfu/ml) of L. rhamnosus strain GG and L. rhamnosus strain LC-705 removed up to 80% 
of AFB1 and L. acidophilus was able to remove up to 68% of AFB1 within 72 h. In the same study, the L. 
casei shirota strain bound up to 34% at 0 h and 58% at 72 h. In another case study by Hernandez-
Mendoza, Garcia, and Steele (2009) on screening L. casei strains for their ability to bind AFB1 in aqueous 
solutions, 14% to 49% of the available aflatoxin was bound. The authors noted that the amount of AFB1 
bound by L. casei was strain specific with the L. casei L30 strain significantly binding more than the 
several other strains examined. Separately, Peltonen, El-Nezami, Salminen, and Ahokas (2000) 
examined the ability of five strains of Lactobacilli and one strain of Bifidobacterium probiotic bacteria 
to bind AFB1. The aflatoxin binding capacity of the two bacterial species was strain specific and the 
quantity bound ranged from 5.8% to 31.3%. Equally, the work by Hernandez-Mendoza, Guzman-De-
Peña, González-Córdova, Vallejo-Córdoba, and Garcia (2010) on In vivo assessment of the potential 
protective effect of L. casei shirota against AFB1, using 15 male Wistar rats, showed that AFB1-Lys 
adducts quantified from blood samples were at significantly lower levels in animals receiving AFB1 plus 
bacteria than in those receiving only AFB1. The finding indicated that the presence of L. casei shirota 
had the ability to reduce aflatoxin absorption at the intestinal level even after a long period of toxin 
exposure. 
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2.9.2 Trichothecenes 
Only limited studies have shown the abilities of various LAB strains to remove type A trichothecenes 
including T-2 toxin. This is in contrast to the enormous effort towards AFB1 studies because of its 
prevalence and more serious toxic effects compared to T-2. Zou et al. (2012) reported some success 
on in vitro removal of DON and T-2 from a mixture of toxins by Lactococcus lactis, L. brevis, L. casei, 
and L. plantarum. The authors noted that all the bacterial strains removed the toxins to varying degrees 
but the ability of the L. plantarum strain was more than other three strains. The strain of L. plantarum 
LP102 was the strongest among the five tested strains at 24 h of fermentation with removal of 
19.90 ± 1.70% of T-2 from a de Man-Rogosa Sharpe (MRS) broth. Thus authors clearly showed that T-
2 removal was strain specific. 
2.10 Mode of removal of mycotoxins by LAB 
Following revelation that LAB were capable of removing mycotoxins from food and feed as well as 
reducing mycotoxin bioavailability, considerable effort has been directed at establishing the mode of 
mycotoxin removal by Lactobacillus. The effects of viable and heat-inactivated, acid- or alkaline-
treated cells on mycotoxin removal have been investigated. El-Nezami, Polychronaki, Salminen, and 
Mykkanen (2002) cultured L. rhamnosus GG and L. rhamnosus LC705 with ZEN and its derivative ά-
zearalenol and at 72 h of incubation no degradation products were observed in the HPLC 
chromatograms. This was an indicator that the strains used in the study were unable to metabolise 
either ZEN or its derivative ά-zearalenol. In the same experiment, both heat-killed and acid-treated 
bacteria were tested on their ability to remove ZEN and its derivative ά-zearalenol. The authors 
reported that both the heat-treated and acid-treated bacteria were capable of removing the toxins 
and binding increased significantly following the treatments. All these indicated that binding and not 
metabolism was the mechanism by which these mycotoxins were removed from the media. 
Previously, Lahtinen et al. (2004) tried to establish the components of the cell envelope that are 
involved in the AFB1 binding process. This was achieved by extracting exopolysaccharides and a cell 
wall isolate containing peptidoglycan from L. rhamnosus strain GG and testing for its AFB1 binding 
properties. The L. rhamnosus strain GG was also subjected to various enzymatic and chemical 
treatments and their effects on the binding of AFB1 by the bacteria were examined. The authors 
reported that there was no evidence for exopolysaccharides, cell wall proteins, Ca2+ or Mg2+ being 
involved in AFB1 binding. AFB1 binding was to the cell wall isolate indicating that AFB1 was bound to 
the cell wall peptidoglycan of L. rhamnosus or compounds tightly associated with the peptidoglycan. 
It was also hypothesized that noncovalent binding was a possible mechanism of mycotoxin removal by 
LAB.The ability of LAB and Saccharomyces cerevisiae to remove AFB1 from liquid medium was also 
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tested by Bueno, Casale, Pizzolitto, Salvano, and Oliver (2007). They noted that AFB1 binding to 
microorganisms was rapid (no more than 1 min), and the binding involved formation of a reversible 
complex between the toxin and microorganism surface, without chemical modification of the toxin, 
and that both viable and heat-treated bacteria produced similar results. Based on these observations, 
the authors concluded that a physical binding (adsorption) and release (desorption) of AFB1 to and 
from the site on the surface of the microorganism would most probably have taken place. 
Despite the great potential benefits that LAB may hold towards reducing human exposure to 
mycotoxins, limited research has been published on isolation of LAB, from probiotic-enriched foods 
such as FMD and conventional yoghurt (CY), to assess their ability to detoxify various concentrations 
of AFB1 and T-2. 
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Chapter 3 
Materials and Methods 
3.1 Materials and reagents 
3.1.1 Samples 
Reference culture of L. acidophilus AS1.3342 was purchased from a microbial culture collection center 
located in Southern China; Guangdong Microbial Culture Collection Center (GIMCC), Guangdong 
Institute of Microbiology, and stored at −20°C until use. Ten bottles of FMD and ten bottles of CY  were 
purchased from a local supermarket, Zhanjiang, China, and transferred to the laboratory under 
refrigeration and stored at 4°C and used before the expiry date. 
3.1.2 Media 
For bacterial isolation and culturing, MRS agar and broth, M17 agar and MRS-sorbital agar 
were used; purchased from QingDao Hopebio-Technology Co., Qingdao, China. 
3.1.3 Chemicals and toxins 
AFB1 and T-2 toxins were purchased from Sigma-Aldrich, China, and stored at −20°C until their use. 
Acetonitrile (99% purity), ethyl acetate and methanol were purchased from Guangfu Si-Tech Co. 
Tianjin, China. 
3.2 Methods 
3.2.1 Isolation and characterization of lactic acid bacteria 
Only one bacterium (L. casei Shirota) was isolated from FMD and three (L. acidophilus, L. bulgaricus 
and Streptococcus thermophilus) from CY. From both FMD and CY, three bottles each of 100 ml were 
aseptically mixed, and 1 ml mixed thoroughly with 9 ml of sterilised phosphate-buffer saline (PBS, pH 
7.2). Serial 10-fold dilutions with PBS were made and 0.1 ml of each dilution spread onto respective 
media. MRS agar was used to isolate the bacterial strain from FMD while MRS (pH 5.2), M17 agar and 
MRS-sorbitol agar were used to isolate the CY strains (the three strains). The agar plates were 
incubated anaerobically at 37°C for 48 h. Colonies were selected and characterised based on the 
criteria shown in Table 1 and maintained as a frozen stock (−20°C) in 50/50 glycerol: MRS broth. 
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Table 1: Isolation and characterization of lactic acid bacteria 
 
3.2.2 Preparation of LAB working cultures 
The reference strain and isolated cultures were grown in MRS broth at 37°C in anaerobic conditions to 
a concentration of 109 cfu/mL. Bacterial concentration was quantified by absorbance at 600 nm (OD600) 
and compared using the standard plate count method. Ten millilitres of broth of each strain were 
centrifuged (7000 × g, 5 min, 4°C), supernatant fluid removed and bacterial pellets collected. The 
pellets were washed twice with 10 mL of PBS and suspended in 10 mL sterile PBS. The FMD strain and 
reference strains were treated as independent cultures while the three strains from CY were mixed to 
form a single culture. 
Bacteria Source Selective 
medium 
Morphological characteristics 
L. bulgaricus Isolated from 
conventional 
yoghurt (CY) 
MRS agar, PH 
adjusted to 5.2 
The colony size about 3–4 mm, circular, 
translucent and white in colour. Gram-
positive and rod-shaped cells 
Streptococcus thermophilus Isolated from CY  M17 agar Colony size about 1–2 mm, circular, 
smooth surface and white in colour. 
Gram-positive and spherical-shaped cells 
that occur in chains resembling a string 
of beads 
L. casei shirota Isolated from 
fermented milk 
drink (FMD) 
MRS agar Colony size about 2–2.5 mm, white, 
circular, smooth & moist surface. 
Gram-positive, rod-shaped bacteria 
L. acidophilus Isolated from CY  MRS-sorbital 
agar 
Colony size 0.5–1 mm, brown, rough 
irregular colonies. 
Gram-positive and rod-shaped cells. 
Cells occur singly, in pairs or in short 
chains 
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3.2.3 Preparation of AFB1 and T-2 standard solutions 
Stock solutions of 7.703 mg/L of AFB1 and 19.601 mg/L of T-2 were prepared by dissolving in 
acetonitrile. Then 0.5 mL of working stock solutions of AFB1 (5000, 2500, 1000, 500 and 250 μg/L) and 
T-2 (12,500, 10,000, 5000, 2500, and 1000 μg/L) were prepared by diluting stock solutions with 
acetonitrile. Working stock solutions were stored at −20°C but warmed to room temperature before 
use. 
3.2.4 Bacterial toxin treatment and toxin extraction 
From each working stock solution of AFB1 and T-2, 20 µL was mixed with 980 µL of each bacterial 
culture and incubated at 37oC for 72 h. The final toxin concentrations were as follows: AFB1 (5, 10, 20, 
50 and 100 μg/L) and T-2 (20, 50, 100, 200 and 250 μg/L). For each bacterial culture, a bacterial control 
(bacteria suspended in PBS) and AFB1 and T-2 controls (20 µL of various working stock concentrations 
of AFB1 and T-2 in 980 µL of PBS) were also incubated. All assays were conducted in duplicate. Following 
incubation, the bacterial toxin mixture and controls were centrifuged (7000 x g, 5 min, 4°C), 0.5mL of 
the supernatant fluid mixed with ethyl acetate, vortexed for 5 min, cleaned by ultrasonic vibration for 
10 min, centrifuged (7000 x g, 5 min, 4°C) and supernatant collected. The same procedure was 
repeated three times and resulting supernatants merged, dried by N2 gas at 50°C, re-dissolved with 1 
mL of 30% methanol and filtered through a 0.22-µm micro-membrane filter. The filtered supernatants 
were assayed for toxin concentrations. 
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Fig. 4: Experimental design for extraction of AFB1 and T-2 toxins. 
3.2.5 LC-MS/MS assay 
The assays of AFB1 and T-2 concentrations were conducted at the National Marine Products Quality 
Supervision & Inspection Centre, Zhanjiang, China. For the T-2 assay, a validated liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) method by Lu et al. (2016) was used. This 
method was slightly modified to optimise the assay for measurement of both AFB1 and T-2. The LC-
MS/MS comprised: a Surveyor MS Pump plus, an online degasser, a Surveyor Auto Sampler Plus 
coupled with a Thermo TSQ Quantum Access tandem mass spectrometer equipped with an 
electrospray ionisation (ESI) source (Massachusetts, USA), and an analytical Hypersil GOLD column 
(5 μm, 100 mm × 2.1 mm) from Thermo Scientific. Methanol was used for mobile phase A, 5 mM 
ammonium acetate and 0.1% formic acid for mobile phase B. Elution was set as follows: 20% A at 
Ethyl acetate 
(1 mL) 
Supernatant 
(0.5 mL) 
 
Add  
Vortex vibration/5 min 
Mix 
Ultrasonic vibration/10 min 
 Centrifugal 7000 x g/5 min/4°C 
Supernatant  
Merge supernatant 
 
Repeat x3 
Dry by N2 / 50°C 
Be re-dissolved with 1ml of 30% methanol solution 
Micro membrane filtration (1 mL) Detection by LC-MS/MS 
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0 min, increased to 90% A from 0 min to 4 min, held at 90% A from 4 min to 7 min, decreased to 20% 
A from 7 min to 7.1 min, and then held at 20% A for 10 min. Flow rate was set at 250 μL/min  and a 
maximal retention time of 6.0 min. The samples and standards were infused directly into the LC-
MS/MS, a 10-μL aliquot injected into the Hypersil GOLD column and operated in the positive ion mode 
using electrospray ionisation. IN the same manner, LC-MS/MS was used to measure AFB1 
concentration. The liquid chromatography conditions were similar to those used for T-2 assessment. 
Maximal retention time was set at 6.0 min. The most intense transition ion products (m/z) of T-2 and 
AFB1 used for quantification on the selected reaction-monitoring (SRM) mode of a mass spectrometer 
were 304.95 m/z and 285.10 m/z.  
3.2.6 Detoxification of T-2 and AFB1 by heat-killed and live cells 
To assess and compare the ability of heat-killed and live cells of LAB to detoxify the two mycotoxins, 
an FMD strain was used. The isolated strain was grown in MRS broth at 37°C in anaerobic conditions 
to a concentration of 109 cfu/mL. Then, 20 ml of broth was centrifuged (7000 × g, 5 min, 4°C), 
supernatant fluid removed and bacterial pellets collected. The pellets were washed twice with 20 mL 
of PBS and then suspended in 20 mL of sterile PBS. The cleaned cells were divided into two portions of 
10 mL each and one portion autoclaved at 121oC for 15 min. From each working stock solution of AFB1 
and T-2, 20 µL was mixed with 980 µL of the cleaned cells and incubated anaerobically at 37°C for 24 
h. A bacterial control and AFB1 and T-2 controls were also incubated. The assays were conducted in 
duplicate. After incubation, the bacterial-toxin mixtures and controls were centrifuged, 0.5 ml of the 
supernatant fluid pipetted and mixed with ethyl acetate, vortexed under vibration for 5 min, cleaned 
by ultrasonic vibration for 10 min, centrifuged (7000 x g, 5 min, 4°C) and the supernatant collected. 
The same procedure was repeated three times and resulting supernatants merged, dried by N2 gas at 
50°C then re-dissolved with 1 mL of 30% methanol solution and finally filtered through a 0.22-µm micro 
membrane filter. Assay of toxin detoxification rate was carried out as described in procedure 3.2.5. 
3.2.7 Viability of live bacterial cells exposed to T-2 and AFB1 
The reference strain, L. casei shirota and L. bulgaricus were grown overnight in MRS broth at 37°C in 
anaerobic conditions to a concentration of 109 cfu/mL. Then, 10 mL broth of each strain were 
centrifuged (7000 × g, 5 min, 4°C), supernatant fluid removed and bacterial pellets collected. The 
pellets were washed twice with 10 mL of PBS and then suspended in 10 mL of sterile PBS. Next, 980 µL 
of each bacterial culture was mixed with 20 µL of various toxin concentrations (refer to procedure 
2.2.3). The bacterial-toxin mixtures were incubated anaerobically at 37°C for 72 h. For each strain, a 
bacterial control (bacteria suspended in PBS) was also incubated. After incubation, serial 10-fold 
dilutions with PBS were made and 0.1 mL of each dilution spread onto MRS agar. The agar plates were 
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incubated anaerobically at 37°C for 48 h. The viable cells were treated as colonies and reported as 
cfu/mL. 
3.3 Statistical analysis 
One-way analysis of variance (ANOVA) was used to determine whether the detoxification rate was 
significantly different between the strains and whether the rate was significantly different between 
toxin concentration levels for individual LAB strains. In the same way, one-way ANOVA was used to 
test for significant differences among means of bacterial viability in toxins. All the assay in this study 
were carried out in duplicate due to the wide range of toxin concentrations, three sets of bacteria and 
time constraint. Minitab 17 statistical software, owned by Minitab Inc., was provided by Lincoln 
University, New Zealand. The software was used to conduct the ANOVA test. The Tukey pairwise test 
was used to compare means. Results were regarded as significant if the p value was < 0.05. 
The results were presented by quantity (μg/L) and percentage (%). The percentage of toxin detoxified 
by the bacteria was calculated using the following formula: 
 % Toxin detoxified =100 x ቘ1- ቀ ࡯࢕࢔ࢉࢋ࢔࢚࢘ࢇ࢚࢏࢕࢔ ࢕ࢌ ࡿࢇ࢓࢖࢒ࢋ
࡯࢕࢔ࢉࢋ࢔࢚࢘ࢇ࢚࢏࢕࢔ ࢕ࢌ ࡿ࢚ࢇ࢔ࢊࢇ࢘ࢊ
ቁ቙ . 
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Chapter 4 
Results 
4.1 Extracted ion chromatograms (T-2 and AFB1) 
The extracted ion chromatograms of samples were captured in a Full Scan-Q1MS scanning 
mode (Figs 5 & 6). The retention times of the AFB1 (Fig. 5) and T-2 (Fig. 6) were 2.83min and 
3.32min respectively. 
 
Fig. 5: Chromatogram for AFB1 by LC-MS/MS; toxin extracted after 72 h incubation with L. casei 
shirota; retention time 2.83 min. The arrow indicates the retention time of the AFB1 metabolite but 
there appears to be only an extremely low concentration of the metabolite. Groopman et al., (1985) 
have shown that the AFB1 metabolite is eluted around the retention time as shown above (arrow). 
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Fig. 6: Chromatogram for T-2 by LC-MS/MS; extracted after 72 h incubation with L. casei shirota; 
retention time 3.32 min. The arrow indicates the retention time of the T-2 metabolite but there 
appears to be only an extremely low concentration of the metabolite. Lu et al., (2016) have shown 
that the AFB1 metabolite is eluted around the retention time as shown above (arrow). 
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4.2 Quantity of AFB1 and T-2 detoxified by live bacteria: FMD strain, 
Reference strain and CY strains 
4.2.1 Quantity of AFB1 detoxified by live bacteria (FMD strain, 
Reference strain and CY strains) 
L. casei shirota and L. acidophilus AS1.3342 detoxified AFB1 by 0.6 -42.9 μg/L (Fig. 7) and 0.5-45.7 μg/L 
(Fig. 8) respectively. The mixture of CY strains detoxified 0.7-42.6 μg/L AFB1 (Fig. 9). The quantity of 
AFB1 detoxified by the live cells of L. casei shirota (r2 = 0.780), L. acidophilus AS1.3342 (r2 = 0.805) and 
CY strains (r2 = 0.829) increased as the toxin concentration increased (Figs 7–9). For individual strains, 
the quantities detoxified between the toxin concentrations were significantly different. However, 
within each level of toxin concentration, there was no significant difference among the means of the 
toxin detoxified by the three bacteria (Fig. 10). 
 
Fig. 7: Quantity of AFB1 detoxified by live FMD isolated strain (L. casei shirota). Various toxin 
concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 72 h. The results are shown as 
mean + standard deviation. Columns with different letters are statistically different (p < 0.05). 
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Fig. 8: Quantity of AFB1 detoxified by live reference strain L. acidophilus AS1.3342. Various toxin 
concentrations and bacteria (109cfu/mL) were incubated at 37°C for 72 h. The results are shown as 
mean + standard deviation. Columns with different letters are statistically different (p < 0.05). 
 
Fig. 9: Quantity of AFB1 detoxified by a mixture of live CY strains (L. bulgaricus, L. acidophilus and 
Streptococcus thermophilus). Various toxin concentrations and bacterial mixture (109 cfu/mL) were 
incubated at 37°C for 72 h. The results are shown as mean + standard deviation. Columns with 
different letters are statistically different (p < 0.05). 
0.5 1.6 5.0
19.1
45.7
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
45.0
50.0
5 10 20 50 100
Q
U
AN
TI
TY
 D
ET
O
XI
FI
ED
 (μ
g/
L)
   
AFB1 CONCENTRATION (μg/L)
Quantity of AFB1 detoxified by live L. acidophilus AS1.3342
L. acidophilus AS1.3342 Linear (L. acidophilus AS1.3342)
r2 = 0.805
a
b
c
cc
0.7 2.8 6.3
18.9
42.6
0.0
10.0
20.0
30.0
40.0
50.0
60.0
5 10 20 50 100
Q
U
AN
TI
TY
 D
ET
O
XI
FI
ED
 (μ
g/
L)
   
AFB1 CONCENTRATION (μg/L)
Quantity of AFB1 detoxified by live cells of CY strains 
Mixture of CY strains Linear (Mixture of CY strains)
r² = 0.829
a
b
ccc
 
 
 
28
 
Fig. 10: Comparison of quantity of AFB1 detoxified by the live bacterial strains in FMD (L. casei 
shirota), Reference (L. acidophilus AS1.3342) and CY (L. bulgaricus, L. acidophilus and Streptococcus 
thermophilus). Various toxin concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 
72 h. One-way ANOVA was used to test significant differences among means at a given 
concentration. There was no significant difference in detoxification by the bacterial strains at each 
toxin concentration. 
 
4.2.2 Quantity of T-2 detoxified by live bacteria (FMD strain, 
Reference strain and CY strains) 
L. casei shirota detoxified T-2 by 3.7–95.6 μg/L (Fig. 11); L. acidophilus AS1.3342 detoxified 2.9–110.8 
μg/L (Fig. 12) and the mixture of CY strains detoxified 3.0–112.0 μg/L (Fig. 13). The quantity of T-2 
detoxified by the live cells of L. casei shirota (r2 = 0.954), L. acidophilus AS1.3342 (r2 = 0.941) and CY (r2 
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by individual strains between the toxin concentrations were significantly different (Figs 11–13). 
However, for CY strains, concentration levels were significantly different beyond 100 μg/L. Except for 
concentration level 200 μg/L, there was no significant difference among the means of the toxin 
detoxified by the three bacteria (Fig. 14). 
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Fig. 11: Quantity of T-2 detoxified by the live FMD isolated strain (L. casei shirota). Various toxin 
concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 72 h. The results are shown as 
mean + standard deviation. Columns with different letters are statistically different (p < 0.05). 
 
Fig. 12: Quantity of T-2 detoxified by the reference strain (L. acidophilus AS1.3342). Various toxin 
concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 72 h. The results are shown as 
mean + standard deviation. Columns with different letters are statistically different (p < 0.05). 
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Fig. 13: Quantity of T-2 detoxified by a mixture of live CY strains (L. bulgaricus, L. acidophilus and 
Streptococcus thermophilus). Various toxin concentrations and bacteria (109 cfu/mL) were incubated 
at 37°C for 72 h. The results are shown as mean + standard deviation. Columns with different letters 
are statistically different (p < 0.05). 
 
Fig. 14: Comparison of quantity of T-2 detoxified by the live FMD (L. casei shirota), Reference 
(L. acidophilus AS1.3342) and CY mixture (L. bulgaricus, L. acidophilus and Streptococcus 
thermophilus). Various toxin concentrations and live bacteria (109cfu/mL) were incubated at 37°C 
for 72 h. One-way ANOVA was used to test significant differences among means within individual 
concentration level. Bacteria with different letters in individual column groups are statistically 
different (p < 0.05). 
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4.3 Percentages of AFB1 and T-2 detoxified by live bacteria: FMD strain, 
Reference strain and CY strains 
4.3.1 Percentages of AFB1 detoxified by live bacteria (FMD strain, 
Reference strain and CY strains) 
L. casei shirota and L. acidophilus AS1.3342 detoxified 11–43% AFB1 (Fig. 15) and 10–46% AFB1 (Fig. 16) 
respectively while the mixture of CY strains detoxified 14–43% AFB1 (Fig. 17). The percentage of AFB1 
detoxified by the live cells of L. casei shirota (r2 = 0.976), L. acidophilus AS1.3342 (r2 = 0.986) and CY 
strains (r2 = 0.936) increased as the toxin concentration increased (Figs 15–17). The percentages 
detoxified between the toxin concentrations were significantly different (Figs 15–17). Within each 
toxin concentration level, there was no significant difference among the means of the toxin detoxified 
by the three bacteria (Fig. 18). 
 
Fig. 15: Percentage of AFB1 detoxified by live FMD isolated strain (L. casei shirota). Various toxin 
concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 72 h. The results are shown as 
mean + standard deviation. Columns with different letters are statistically different (p < 0.05). 
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Fig. 16: Percentage of AFB1 detoxified by live reference strain (L. acidophilus AS1.3342). Various toxin 
concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 72 h. The results are shown as 
mean + standard deviation. Columns with different letters are statistically different (p < 0.05). 
Fig. 17: Percentage of AFB1 detoxified by a mixture of live CY strains (L. bulgaricus, L. acidophilus and 
Streptococcus thermophilus). Various toxin concentrations and bacterial mixture (109 cfu/mL) were 
incubated at 37°C for 72 h. The results are shown as mean + standard deviation. Columns with 
different letters are statistically different (p < 0.05). 
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Fig. 18: Comparison of percentage of AFB1 detoxified by the live bacterial strains in FMD (L. casei 
shirota), Reference (L. acidophilus AS1.3342) and CY mixture (L. bulgaricus, L. acidophilus and 
Streptococcus thermophilus). Various toxin concentrations and bacteria (109 cfu/mL) were incubated 
at 37°C for 72 h. One-way ANOVA was used to test for significant differences among means at 
individual concentration levels. There was no significant difference in detoxification by the bacterial 
strains at each toxin concentration. 
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4.3.2 Percentages of T-2 detoxified by live bacteria (FMD strain, 
Reference strain and CY strains) 
L. casei shirota and L. acidophilus AS1.3342 detoxified 19–38% (Fig. 19) and 15–45% (Fig. 20) 
respectively. The mixture of CY strains detoxified 15–45% (Fig. 21). T-2 detoxified by the live cells of 
L. casei Shirota (r2 = 0.983), L. acidophilus AS1.3342 (r2 = 0.900), and CY strains (r2 = 0.964) increased 
as the toxin concentration increased (Figs 19–21). The percentages detoxified by the various strains 
between the toxin concentrations were significantly different (Figs 19–21). There was no significant 
difference among the means of the toxin detoxified by the three bacteria at each toxin concentration 
(Fig. 22). 
 
Fig. 19: Percentage of T-2 detoxified by the live FMD-isolated strain (L. casei shirota). Various toxin 
concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 72 h. The results are shown as 
mean + standard deviation. Columns with different letters are statistically different (p < 0.05). 
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Fig. 20: Percentage of T-2 detoxified by the Reference strain (L. acidophilus AS1.3342). Various toxin 
concentrations and bacteria (109cfu/mL) were incubated at 37°C for 72 h. The results are shown as 
mean + standard deviation. Columns with different letters are statistically different (p < 0.05). 
 
Fig. 21: Percentage of T-2 detoxified by a mixture of live CY strains (L. bulgaricus, L. acidophilus and 
Streptococcus thermophilus). Various toxin concentrations and bacteria (109 cfu/mL) were incubated 
at 37°C for 72 h. The results are shown as mean + standard deviation. Columns with different letters 
are statistically different (p < 0.05). 
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Fig. 22: Comparison of percentages of T-2 detoxified by the live FMD (L. casei shirota), Reference (L. 
acidophilus AS1.3342) and CY (L. bulgaricus, L. acidophilus and Streptococcus thermophilus) strains 
at each toxin concentration. Various toxin concentrations and live bacteria (109 cfu/mL) were 
incubated at 37°C for 72 h. One-way ANOVA was used to test for significant differences among 
means at a given concentration. Bacteria with different letters within individual column groups are 
statistically different (p < 0.05). 
 
 
 
 
 
0
10
20
30
40
50
60
2502001005020
T-
2 
DE
TO
XI
FI
ED
 (%
)
T-2 CONCENTRATION (μg/L)
Comparison of percentages of T-2 detoxified by live bacteria 
isolated from yoghurts & reference strain
L. casei shirota L. acidophilus AS1.3342 Mixture of CY strains
a
a a
a
a
a a
a a
b
a
a
a
a
a
 
 
 
37
4.4 Quantity of AFB1 and T-2 detoxified by live and denatured L. casei 
shirota 
4.4.1 Quantity of AFB1 detoxified by live and denatured L. casei 
shirota 
The absolute quantity of AFB1 detoxified by both live and denatured cells of L. casei shirota increased 
as the toxin concentration increased (Figs 23 & 24). Live cells detoxified 0.6–46.6 µg/L AFB1 (Fig. 23) 
compared to 3.4–47.5 µg/L detoxified by denatured bacteria (Fig. 24). Thus denatured L. casei shirota 
cells (r² = 0.867) detoxified a greater quantity of AFB1 toxin than the live cells (r2 = 0.837) (Fig. 25). The 
quantity detoxified by the live cells or denatured cells were significantly different between the 
concentration levels (Figs 23 & 24). 
 
Fig. 23: Quantity of AFB1 detoxified by live cells of L. casei shirota at various toxin concentrations. 
Various toxin concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 24 h. The results 
are shown as mean + standard deviation. Columns with different letters are statistically different 
(p < 0.05). 
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Fig. 24: Quantity of AFB1 detoxified by denatured cells of L. casei shirota at various toxin 
concentrations. Various toxin concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 
24 h. The results are shown as mean + standard deviation. Columns with different letters are 
statistically different (p < 0.05). 
 
Fig. 25: Comparison of quantity of AFB1 detoxified by live and denatured cells of L. casei shirota at 
individual toxin concentration level. Various toxin concentrations and bacteria (109 cfu/mL) were 
incubated at 37°C for 24 h. One-way ANOVA was used to test for significant differences between 
means at a given concentration. The results are shown as mean + standard deviation. Treatments 
with different letters in individual column groups are statistically different (p < 0.05). 
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4.4.2 Quantity of T-2 detoxified by live and denatured L. casei 
shirota 
The quantity of T-2 detoxified by both denatured and live cells of L. casei shirota increased as the toxin 
concentration increased (Figs 26 & 27). Live cells detoxified 5.6–94.8 µg/L T-2 (Fig. 26). Denatured cells 
detoxified 10.4–101.7 µg/L (Fig. 27). Thus, denatured L. casei shirota cells (r² = 0.938) detoxified a 
greater quantity of AFB1 toxin than the live cells (r2 = 0.978) (Fig. 28). The quantities detoxified by the 
live cells or denatured cells were significantly different between the concentration levels (Figs 26 & 
27). There was a significant difference in the amount detoxified between the live and denatured cells 
(Fig. 28). However, the difference was only significant at 20, 50 and 100 µg/L but insignificant at 200 
and 250 µg/L (Fig. 20). 
 
Fig. 26: Quantity of T-2 detoxified by live cells of L. casei shirota at various toxin concentrations. 
Various toxin concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 24 h. The results 
are shown as mean + standard deviation. Columns with different letters are statistically different 
(p < 0.05). 
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Fig. 27: Quantity of T-2 detoxified by denatured cells of L. casei shirota at various toxin 
concentrations. Various toxin concentrations and bacteria (109cfu/mL) were incubated at 37°C for 
24 h. The results are shown as mean + standard deviation. Columns with different letters are 
statistically different (p < 0.05). 
 
Fig. 28: Comparison of quantity of T-2 detoxified by both denatured and live cells of L. casei shirota 
at various toxin concentrations. Various toxin concentrations and bacteria (109 cfu/mL) were 
incubated at 37°C for 24 h. One-way ANOVA was used to test for significant differences between 
means at a given concentration. The results are shown as mean + standard deviation. Treatments 
with different letters in Individual column groups are statistically different (p < 0.05). 
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4.5 Percentages of AFB1 and T-2 detoxified by live and denatured 
L. casei shirota 
4.5.1 Percentage of AFB1 detoxified by live and denatured L. casei 
shirota 
The percentage detoxified by denatured cells decreased (not significantly) as the toxin concentration 
increased (Fig. 29) while the percentage detoxified by live cells increased, significantly, as toxin 
concentration increased (Fig. 30). Denatured cells detoxified between 48% and 62% of AFB1 (Fig. 29) 
while live cells detoxified between 12% and 47% (Fig. 30). There was a significant difference in the 
percentage of AFB1 detoxified between the live and denatured cells (Fig. 31). 
 
Fig. 29: Percentage of AFB1 detoxified by denatured cells of L. casei shirota at various toxin 
concentrations. Various toxin concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 
24 h. The results are shown as mean + standard deviation. Columns with different letters are 
statistically different (p < 0.05). 
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Fig. 30: Percentage of AFB1 detoxified by the live cells of L. casei shirota at various toxin 
concentrations. Various toxin concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 
24 h. The results are shown as mean + standard deviation. Columns with different letters are 
statistically different (p < 0.05). 
 
Fig. 31: Comparison of percentages of AFB1 detoxified by live and denatured cells of L. casei shirota 
at individual toxin concentration level. Various toxin concentrations and bacteria (109 cfu/mL) were 
incubated at 37°C for 24 h. One-way ANOVA was used to test for significant differences between 
means at a given concentration. The results are shown as mean + standard deviation. Treatments 
with different letters in individual columns are statistically different (p < 0.05). 
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4.5.1 Percentage of T-2 detoxified by live and denatured L. casei 
shirota 
The percentage of T-2 detoxified by live cells increased as the toxin concentration increased (Fig. 32). 
The percentage detoxified by denatured cells decreased (not significantly) as the toxin concentration 
increased (Fig. 33). Live cells detoxified between 28% and 40% of AFB1 (Fig. 32) while denatured cells 
detoxified between 42% and 53% (Fig. 33). There was a significant difference in the percentage of T-2 
detoxified between the live and denatured cells at 20, 50 and 100 µg/L (Fig. 34). However, at 200 and 
250 µg/L T-2 concentrations, the differences between the live and the denatured cells were 
insignificant (Fig. 34). 
 
Fig. 32: Percentage of T-2 detoxified by the live cells of L. casei shirota at various toxin 
concentrations. Various toxin concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 
72 h. The results are shown as mean + standard deviation. Columns with different letters are 
statistically different (p < 0.05). 
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Fig. 33: Percentage of T-2 detoxified by the denatured cells of L. casei shirota at various toxin 
concentrations. Various toxin concentrations and bacteria (109 cfu/mL) were incubated at 37°C for 
72 h. The results are shown as mean + standard deviation. Columns with different letters are 
statistically different (p < 0.05). 
 
Fig. 34: Comparison of percentages of T-2 detoxified by live and denatured cells of L. casei shirota at 
individual toxin concentration level. Various toxin concentrations and bacteria (109 cfu/L) were 
incubated at 37°C for 24 h. One-way ANOVA was used to test for significant differences between 
means at a given concentration. The results are shown as mean + standard deviation. Treatments 
with different letters in individual column groups are statistically different (p < 0.05). 
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4.6 Cell viability (cells treated with AFB1 and T-2) 
The viability of bacterial cells declined with increase in toxin concentration (Tables 2 & 3) and time 
(Appendix Tables A5–A10). After incubation for 72 h, reduction of AFB1 by L. casei shirota was in the 
range of 0.2% to 18.3%, by L. acidophilus AS1.3342 between 0.3% to 14.5% and L. bulgaricus between 
4.2% to 8.2% (Table 2). Similarly, reduction of L. casei shirota in T-2 was in the range 0.2% to 13.6%, L. 
acidophilus AS1.3342 1.0% to 19.0% and L. bulgaricus 4.7% to 6.1% (Table 3). 
Table 2: Viability of cells treated in AFB1 toxin; 72 h incubation (L. casei shirota, L. acidophilus 
AS1.3342 and L. bulgaricus) 
AFB1 concentrations 
Bacterial viability (%) after 72 h incubation 
L. casei shirota 
(%) 
L. acidophilus 
AS1.3342 (%) L. bulgaricus (%) 
5 µg/L 18.3 a (+0.8) 14.5 a (+1.9) 8.2 a (+0.6) 
10 µg/L 4.4 b (+0.1) 12.5 (+0.9) 7.8 ab (+0.6) 
20 µg/L 1.7 c (+0.2) 1.4 (+0.2) 5.9 bc (+0.3) 
50 µg/L 0.6 cd (+0.2) 1.2 (+0.0) 4.5 c (+0.6) 
100 µg/L 0.2 d (+0.0) 0.3 (+0.1) 4.2 c (+0.4) 
The percentage of cell viability for each strain was calculated by dividing the number of live cells in the 
toxin by the number of live cells in the respective controls. Values in bracket are the standard deviation. 
One-way ANOVA was used to test for significant differences among means within an individual 
concentration level. Values in individual columns with different letters are statistically different (p < 
0.05). 
Table 3: Viability of cells treated in T-2 toxin; 72 h incubation (L. casei shirota, L. acidophilus AS1.3342 
and L. bulgaricus) 
T-2 concentrations 
Bacterial viability (%) after 72 h incubation 
L. casei shirota 
(%) 
L. acidophilus 
AS1.3342 (%) L. bulgaricus (%) 
20 µg/L 13.6 a (+0.4) 19.0 a (+1.4) 6.1 a (+0.3) 
50 µg/L 1.7 b (+0.1) 15.6 b (+1.0) 5.6 ab (+0.3) 
100 µg/L 1.0 bc (+0.1) 10.1 c (+0.4) 5.1 ab (+0.3) 
200 µg/L 0.3 c (+0.1) 3.3 d (+0.5) 4.8 b (+0.1) 
250 µg/L 0.2 c (+0.0) 1.0 d (+0.0) 4.7 b (+0.1) 
The percentage of cell viability for each strain was calculated by dividing the number of live cells in the 
toxin by the number of live cells in the respective controls. One-way ANOVA was used to test for 
significant differences between means within an individual concentration level. Values in individual 
columns with different letters are statistically different (p < 0.05). 
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4.7 Comparison between death rate of live bacterial cells and AFB1 
detoxified 
As bacterial death rate increased, so did detoxification of AFB1 increase (Fig. 35) 
 
Fig. 35: A comparative profiles of bacterial death rate vs percentage of AFB1 detoxified by L. casei 
shirota after incubation in AFB1 for 72 h. Cells were initially cultured to 109 cfu/mL. 
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4.8 Comparison between death rate of live bacterial cells and T-2 
detoxified 
An increase in cell death rate resulted in an increase in percent of T-2 detoxified (Fig. 36) 
 
Fig. 36: A comparative profile of bacterial death rate vs percentage of T-2 detoxified by L. casei 
shirota after incubation in T-2 for 72 h. Cells were initially cultured to 109 cfu/mL. 
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Chapter 5 
Discussion 
The choices of incubation temperature (37°C), bacterial concentration (109 CFU/mL) and incubation 
time periods (24 & 72 h) were based on information from some previous publications. A study by El-
Nezami, Kankaanpaa, Salminen, and Ahokas (1998) reported that the rate of mycotoxin removal was 
both temperature and bacterial concentration dependent and that maximal removal of mycotoxin 
occurred at 37°C. El-Nezami, Chrevatidis, Auriola, Salminen, and Mykkanen (2002) and Peltonen, El-
Nezami, Haskard, Ahokas, and Salminen (2001) recommended 109 cfu/mL as the minimum 
concentration of LAB in the incubation medium that could cause a significant removal of mycotoxins. 
The bacterial toxin mixtures were incubated for either 24 or 72 h, a range that falls within the 
estimated time frame of 1–3 days for food residue to pass through the human gut (Cummings, Jenkins, 
& Wiggins, 1976). 
The mechanism of toxin removal by LAB has been hypothesised to be by binding rather than 
biodegradation. For example, in an experiment by Niderkorn, Boudra, and Morgavi (2006), 
biodegradation did not appear to be the mode of action for removal of DON and fumonisins (B1 and 
B2) because no toxin metabolites were observed and removal was not impaired in non-viable bacteria. 
Similarly, in my research, binding rather than biodegradation was hypothesized as the mode of toxin 
removal by the LAB species. This is supported by the fact that both live and denatured cells (Fig. 31 & 
34) were capable of removing AFB1 and T-2 to a similar extent. It is also supported by the lack of 
biodegradation products in the AFB1 and T-2 chromatograms (Fig. 5 & 6). This is also in agreement with 
observations made by El-Nezami, Polychronaki, et al. (2002) that indicated  metabolites or degradation 
products were not detected when ZEN was incubated with L. rhamnosus GG. Along the same lines, 
Haskard, El-Nezami, Kankaanpaa, Salminen, and Ahokas (2001) showed that there was a strong 
evidence of effective AFB1 removal of by all nonviable bacteria through binding rather than via 
metabolism. As regards a detailed investigation to reveal the binding mechanism, Lahtinen et al. (2004) 
isolated exopolysaccharides and a cell wall isolate containing peptidoglycan from L. rhamnosus strain 
GG and tested their ability to remove AFB1. The L. rhamnosus strain GG was also subjected to various 
enzymatic and chemical treatments, and their effects on the binding of AFB1 by the bacteria were 
confirmed. In such aforementioned research, the authors reported that there was no evidence for 
exopolysaccharides, cell wall proteins, Ca2+ or Mg2+ being involved in AFB1 binding. AFB1 binding 
appeared to be to the cell wall isolate, indicating that AFB1 is bound to the cell wall peptidoglycan of 
L. rhamnosus or compounds tightly associated with the peptidoglycan. The authors reported that 
binding was the mechanism by which LABs detoxified the toxin from the media. 
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My study has revealed that LAB isolated from food can remove AFB1 and T-2 from the media. L. casei 
shirota detoxified between 0.6 and 42.9 μg/L AFB1 (Fig. 7) and 3.7–95.6 μg/L T-2 (Fig. 11). L. acidophilus 
AS1.3342 detoxified between 0.5 and 45.7 μg/L AFB1 (Fig. 8) and 2.9–110.8 μg/L T-2 (Fig. 12). The 
mixture of CY strains detoxified 0.7–42.6 μg/L AFB1 (Fig. 9) and 3.0–112.0 μg/L T-2 (Fig. 13). Expressed 
as a percentage, L. casei shirota detoxified 11–43% AFB1 (Fig. 15) and 19–38% T-2 (Fig. 19). 
L. acidophilus AS1.3342 detoxified 10–46% AFB1 (Fig. 16) and 15–45% T-2 (Fig. 20). The mixture of CY 
strains detoxified 14–43% AFB1 (Fig. 17) and 15–45% T-2 (Fig. 21). There was no significant difference 
among the means of the three strains in toxin removal. These findings were similar to the observations 
made by Haskard et al. (2001) where the viable cells of L. casei shirota, L. acidophilus LC1 isolated from 
food and a pure culture of L. acidophilus ATCC 4356 were able to remove up to 21.8%, 59.7% and 48.3% 
of AFB1 respectively. The results in this study also mirrored data observed by Zou et al. (2012) on the 
ability of four strains of LAB species and one strain of Lactococcus species to remove DON and T-2 from 
MRS broth. This study by Zou et al. (2012), demonstrated that the tested strains had the ability to 
remove DON and T-2. However, the rate of toxin removal depended on the bacterial strain with the 
strains of L. plantarum showing the highest T-2 removal at 19.90 ± 1.70%. In another closely related 
study involving assessment of the abilities of yoghurt starter cultures (L. bulgaricus and Streptococcus 
thermophilus) to remove aflatoxin M1 (AFM1) from yoghurt and PBS medium, El Khoury, Atoui, and 
Yaghi (2011) found that yoghurt starter cultures were able to remove AFM1 in yoghurt and PBS but the 
rate of removal was higher by the bacteria in yoghurt than by the PBS. Similarly, Elsanhoty, Salam, 
Ramadan, and Badr (2014) revealed that the addition of probiotic LAB to starter cultures increased the 
rate of AFM1 removal during yoghurt production and storage. Halttunen, Collado, El-Nezami, 
Meriluoto, and Salminen (2008) also showed that the toxin-removal capacity of a combination of 
strains of LAB bacteria did not conform to the sum of toxin removal by the individual bacteria. My 
results are in agreement with these in that the toxin removal rate by a mixture of CY strains (L. 
bulgaricus, L. acidophilus and Streptococcus thermophilus) was not significantly different to the 
removal by the reference culture used in my experiment (Figs 18 & 22). 
As shown in Figs 23 and 26, the quantity of AFB1 and T-2 detoxified by the live cells of the FMD strain 
increased as toxin concentration increased. This observation supports the report by El-Nezami et al. 
(1998) which indicated that the quantity of AFB1 detoxified increased with increasing concentration of 
the toxin. However, it contrasts with Line and Brackett (1995) who showed that the percentage of AFB1 
detoxified was lower as the toxin levels increased. The most probable explanation for the linear 
increase in percentage detoxified by live LAB was deemed to be the cell viability. This proposition was 
tested by comparing the detoxification of the two toxins by both live and denatured cells of the FMD 
strain and by analysing the effect of toxin concentrations on LAB. When either live or denatured cells 
of L. casei shirota were exposed to various concentrations of AFB1, the quantity of toxin detoxified 
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increased as the toxin concentration increased (Figs 23 & 24). Denatured L. casei shirota cells 
detoxified a greater quantity of AFB1 toxin than the live cells (Fig. 25). Similarly, when both the live and 
denatured cells of L. casei shirota were exposed to various concentrations of T-2, the quantity 
detoxified by both the denatured and live cells increased as the toxin concentration increased (Figs 26 
& 27). There was a significant difference in the amount of T-2 detoxified between the live and 
denatured cells (Fig. 28). However, the difference was only significant at 20, 50 and 100 µg/L 
concentrations and not at 200 and 250 µg/L (Fig. 20). Thus 100 µg/L could be treated as the effect 
threshold for both the live and denatured cells. The second action to test the proposition involved 
mixing the viable cells with various toxin concentrations and determining LAB viability after incubation 
for different periods. From the experiment, it was apparent that when the viable LAB cells were mixed 
with various concentrations of AFB1 or T-2 and incubated at 37°C for a total of 72 h, there was a 
significant decrease in cell viability with increase in toxin concentration (Tables 2 & 3). Cell viability also 
declined with increase in incubation time (Tables B5–B10 in appendix B). As shown in Fig. 35 and 36, 
detoxification rate increased with the increase in dead (non-viable) cells. Lower toxin concentrations 
had lower cell death resulting in lower toxin removal (absolute quantity and as a percentage). Based 
on these observations, it was apparent that as the cell viability decreased, the toxin removal increased. 
A closely related observation was made by Line and Brackett (1995), who reported that more AFB1 
were detoxified by 72-h cultures of Flavobacterium aurantiacum than by 24-h cultures; probably due 
to the presence of more dead cells in the 72-h culture than the 24-h culture. 
AFB1 and T-2 removal rates by denatured L. casei shirota cells were significantly higher than by the live 
cells (Figs 31 & 34). An experiment by Oluwafemi and Da-Silva (2009) on removal of aflatoxins by viable 
and heat-killed LAB species isolated from fermented maize reported a significant difference between 
the heated and live LAB species. It was noted that the detoxification was significantly higher in the 
experiment that used heat treated cells. The authors reported that autoclaving led to denaturation of 
bacterial proteins and enzymes leaving behind the peptidoglycan that provided a favourable binding 
medium. The original binding sites of the viable microorganisms may have changed by heat treatment 
thereby exposing new binding sites.  
In my experiments, when a comparison was made between the percentage (%) and quantity (µg/L) 
detoxified by denatured cells of L. casei shirota, the absolute quantity of toxin detoxified by denatured 
cells increased with increase in toxin concentration (Fig. 24 & 27) while in percentage terms, there was 
a decrease with increase in toxin concentration but the decrease was not significant (Fig. 29 & 33). It 
is possible that after heat treatment, the peptidoglycan of LAB or compounds tightly associated with 
the peptidoglycan were already exposed, meaning the denatured LAB cells could easily reach their 
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absorption saturation points hence any additional toxin concentration only contributed to a reduction 
in percentage detoxified. 
Another significant observation from this project is that LAB either in a viable or non-viable state were 
efficient in toxin removal and hence would be useful for treatment of digestive syndromes at least in 
the early stages of exposure to toxins when most of the toxin(s) are still in the gastrointestinal tract. 
For example, El-Nezami et al. (2000) reported that a mixture of Lactobacillus and Propionibacterium 
were capable of Influencing the faecal aflatoxin content in healthy Egyptian volunteers. Volunteers 
who were administered the probiotic preparation recorded a significant reduction in the level of 
AFB1 after the second week of the trial and further reduction during the follow up period. Faecal 
levels of aflatoxin were thought to reflect the exposure to aflatoxin. 
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Chapter 6 
Conclusions 
In this study, it was demonstrated that LAB isolated from some foods such as fermented milk and 
yoghurt type foods possess the ability to detoxify AFB1 and T-2. Toxin removal by the bacteria isolated 
from the foods and the reference cultures were similar. The relationship between detoxification rate 
and toxin concentrations was demonstrated. At a bacterial concentration of 109 cfu/mL, toxin removal 
increased with toxin concentration. However, there appeared to be a threshold for T-2 beyond which 
there was no significant difference in toxin removal between toxin concentrations. This was at 100 
µg/L for T-2. Equally, the impact of cell viability on detoxification was highlighted. It was shown that 
both live and denatured cells possessed the ability to remove AFB1 and T-2. This is of significance 
because it demonstrates that probiotics, despite their universally accepted definition, still have the 
ability to remove toxins even in a non-viable state and possibly pass health benefits to the consumers 
by reducing exposure to mycotoxins. Based on the findings of this project, I believe that these LAB can 
act as biological agents for AFB1 and T-2 reduction by binding the mycotoxins and thereby reducing 
their absorption via the gastrointestinal tract into the blood. However, to ascertain this benefit, further 
research such as clinical trials (in vivo tests), particularly those aimed at assessing the ability of 
probiotic-enriched foods to reduce mycotoxin absorption into the blood and also tissue kinetic studies 
need to be carried out. 
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Appendix A 
Health and safety hazards and control measures 
Potential health and safety hazards are summarised in Table A1. 
Table A 1: Potential health and safety hazards and proposed control measures 
Location Hazards Management 
Laboratory Chemicals, mycotoxins 
and microorganisms 
Use protective clothing: lab coats, closed footwear, nose 
mask, hand gloves, goggles or visors as required. 
Follow instructions on the label of containers. 
Waste to be disposed of in the correct bags. Microbe 
waste only in the bio-hazard bin. 
Chemicals to be stored in the appropriate storage 
facilities with appropriate labelling. 
Hands to be washed after all lab work is completed 
Laboratory UV light on in biosafety 
cabinet 
UV light to be switched off before working in the 
biosafety cabinet 
Laboratory Back, wrist and eye pain 
from microscope work 
Ensure seat height is correctly adjusted and supportive. If 
using glasses, ensure they are detoxified before observing 
through the microscope lens. 
Adjourn for short breaks 
Work station Hand, back and eye strain 
using computer for 
prolonged periods 
Adjust chair to correct height and in position with respect 
to monitor, keyboard and working table. Obtain 
appropriate supports for feet and back. 
Adjourn for short breaks 
Occupational 
Overuse 
Syndrome 
Performing a repetitive 
task over a long time 
Regular breaks and undertaking alternate tasks 
Travels Road motor accidents When travelling in a personal car, ensure the vehicle is 
safe and fully certified. When using hired car, ensure the 
vehicle is safe, fully certified and driven by approved 
licence-holding driver 
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Appendix B 
Summary of statistical analysis 
Table B1: Statistical results for AFB1 detoxification rate at 5 µg/L (FMD strain, CY strains and 
Reference strain) 
Source  DF Adj SS  Adj MS  F-Value  P-Value 
Bacteria 2 17.33  8.667  2.17  0.262 
Error  3 12.00   4.000 
Total  5 29.33 
 
S R-sq  R-sq(adj) R-sq(pred) 
2 59.09%  31.82%  0.00% 
The detoxification rate among the means of the three treatments (FMD strain, CY strains and 
Reference strain) were not significantly different (p < 0.05). 
Table B2: Statistical results for T-2 detoxification rate at 20 µg/L (FMD strain, CY strains and 
Reference strain) 
Source  DF Adj SS  Adj MS  F-Value  P-Value 
Bacteria 2 24.33  12.167  2.92  0.198 
Error  3  12.50  4.167 
Total       5    36.83 
 
S  R-sq  R-sq(adj) R-sq(pred) 
2.04124 66.06%  43.44%  0.00% 
The detoxification rate among the means of the three treatments (FMD strain, CY strains and 
Reference strain) were not significantly different (p < 0.05). 
Table B3: Statistical results for detoxification of 5 µg/L of AFB1 by the live and denatured cells of 
L. casei shirota 
Source  DF Adj SS  Adj MS  F-Value  P-Value 
Bacteria 1 2601.00 2601.00 5202.00 0.000 
Error  2 1.00  0.50 
Total  3 2602.00 
 
       S  R-sq  R-sq(adj) R-sq(pred) 
0.707107 99.96%  99.94%       99.85% 
The detoxification rates between the live and denatured cells were significantly different (p < 0.05). 
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Table B4: Statistical results for detoxification of 20 µg/L of T-2 by the live and denatured cells of 
L. casei shirota 
Source  DF Adj SS  Adj MS  F-Value  P-Value 
Bacteria 1 625.000 625.000 625.00     0.002 
Error  2 2.000  1.000 
Total  3 627.000 
 
S  R-sq  R-sq(adj) R-sq(pred) 
1 99.68%  99.52%  98.72% 
There was a significant difference between the live and denatured cells in detoxification of T-2. 
 
 
Table B5: Viability of L. casei shirota exposed to various concentrations of AFB1 and in control 
L. casei shirota 
AFB1 
concentrations 
Bacterial load (cfu/mL) after 
incubation with AFB1 
 
Bacterial load in control sample 
(cfu/mL) after incubation 
Incubation 
time 
 
24 h 48 h 72 h 24 h 48 h 72 h 
Toxin 
concentrations 
5 µg/L 2.8x108a 
(5.1) 
2.9x107a 
(2.5)  
8.3x106a 
(4.3)  
3.8x109 
(9.4) 
2.9x108 
(12.4) 
4.5x107 
(15.7) 
10 µg/L 1.50x108b 
(4.9) 
2.0x107b 
(7.1)  
2.0x106b 
(1.8)  
20 µg/L 1.1x108c 
(9.9)  
3.9x106c 
(3.6)  
7.5x105c 
(9.4)  
50 µg/L 8.7x107cd 
(4.9)  
3.0x106cd 
(7.2) 
2.5x105c 
(28.3)  
100 µg/L 5.6x107d 
(11.5) 
5.3x105d 
(6.7)  
1.0x105 d 
(14.1) 
Each value of bacterial load is a mean of duplicate assays using the standard plate count method. The 
samples were incubated at 37°C. Pre-incubation bacterial load was 8.3 x 109 cfu/mL. Values in brackets 
are coefficient of variation expressed as percentage. Values in individual columns with different letters 
are statistically different (p < 0.05). All the controls were significantly different from their respective 
treatments. 
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Table B6: Viability of L. casei shirota exposed to various concentrations of T-2 and in control 
L. casei shirota 
T-2 
Concentrations 
Bacterial load (cfu/mL) after 
incubation with T-2 
 
Bacterial load in control 
sample (cfu/mL) after 
incubation 
Incubation 
time 
 
24 h 48 h 72 h 24 h 48 h 72 h 
Toxin 
concentrations 
20 µg/L 1.4x109a 
(2.3)  
2.4x107a 
(6.7)  
4.9x106a 
(8.3)  
3.7x109 
(5.8) 
3.6x108 
(17.9) 
3.6x107 
(15.7) 
50 µg/L 8.1x108b 
(8.3)  
1.1x107b 
(8.3)  
6.2x105b 
(18.4)  
100 µg/L 1.8x108c 
(4.0)  
9.2x106bc 
(2.3)  
3.8x105bc 
(9.4)  
200 µg/L 8.5x107d 
(0.9)  
2.6x106cd 
(9.9)  
1.2x105cd 
(3.4)  
250 µg/L 6.1x107d 
(3.0)  
1.1x106d 
(15.0)  
8.5x104d 
(2.9)  
Each value of bacterial load is a mean of duplicate assays using the standard plate count method. The 
samples were incubated at 37°C. Pre-incubation bacterial load was 8.3 x 109 CFU/mL. Values in brackets 
are coefficient of variation expressed as percentage. Values in individual columns with different letters 
are statistically different (p < 0.05). All the controls were significantly different from their respective 
treatments. 
Table B7: Viability of L. acidophilus AS1.3342 in various concentrations of AFB1 and control 
L. acidophilus 
AS1.3342 
AFB1 
Concentrations 
Bacterial Load (cfu/mL) after 
incubation with AFB1 
 
Bacterial load in control sample 
(cfu/mL) after incubation 
Incubation time  24 h 48 h 72 h 24 h 48 h 72 h 
Toxin 
concentrations 
5 µg/L 3.2x107a 
(6.7) 
5.9x106a 
(2.4) 
1.1x106a 
(12.9)  
5.9x108 
(3.6) 
5.8x107 
(6.1) 
7.6x106 
(11.2) 
10 µg/L 2.5x107b 
(2.9)  
4.3x106b 
(8.3) 
9.5x105a 
(7.4) 
20 µg/L 7.8x106c 
(4.6)  
8.8x105c 
(4.0)  
1.1x105b 
(12.9) 
50 µg/L 2.5x106c 
(5.7) 
2.5x105cd 
(28.3) 
8.8x104b 
(4.0) 
100 µg/L 7.6x106d 
(7.4) 
1.1x105d 
(12.9) 
2.5x104b 
(28.3) 
Each value of bacterial load is a mean of duplicate assays using the standard plate count method. Pre-
incubation bacterial load was 3.8 x 109 CFU/mL. The samples were incubated at 37°C. Values in brackets 
are coefficient of variation expressed as percentage. Values in individual columns with different letters 
are statistically different (p < 0.05). All the controls were significantly different from their respective 
treatments. 
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Table B8: Viability of L. acidophilus AS1.3342 in various concentration of T-2 and control 
L. acidophilus 
AS1.3342 
T-2 
concentrations 
Bacterial load (cfu/mL) after 
incubation with T-2  
 
Bacterial load in control sample 
(cfu/mL) after incubation 
Incubation 
time 
 
24 h 48 h 72 h 24 h 48 h 72 h 
Toxin 
concentrations 
20 µg/L 3.3x108a   
(3.9) 
3.0x107a 
(0.0) 
4.1x106a 
(1.0) 
5.8 x108 
(1.2) 
6.3x107 
(6.7) 
6.8x106 
(5.2) 
50 µg/L 2.6x108 b 
(7.4) 
1.1x107b 
(2.3) 
1.1x106b 
(15.7) 
100 µg/L 8.6x107 c 
(7.4) 
7.1x106c 
(2.0)  
6.8x105c 
(4.2) 
200 µg/L 5.7x107 d 
(2.8) 
3.1x106d 
(12.9)  
2.3x105d 
(6.7) 
250 µg/L 7.2x106 e 
(2.2) 
8.2x105d 
(2.4) 
7.1x104d 
(1.7) 
Each value of bacterial load is a mean of duplicate assays in the standard plate count method. The 
samples were incubated at 37°C. Pre-incubation bacterial load was 3.8 x 109 CFU/mL. Values in brackets 
are coefficient of variation expressed as percentage. Values in individual columns with different letters 
are statistically different (p < 0.05). All the controls were significantly different from their respective 
treatments. 
Table B9: Viability of L. bulgaricus in various concentrations of AFB1 and in control 
L. bulgaricus 
AFB1 
Concentrations 
Bacterial Load (cfu/mL) after 
incubation with AFB1 
 
Bacterial load in control sample 
(cfu/mL) after incubation 
Incubation time  24 h 48 h 72 h 24 h 48 h 72 h 
Toxin 
concentrations 
5 µg/L 4.3 x107 a 
(1.7) 
3.9x106 c 
(1.8)  
2.0x106 a 
(7.1) 
4.4x108 
(1.6) 
3.2x107 
(6.7) 
2.5x106 
(8.7) 
10 µg/L 4.0x107 ab 
(1.8) 
3.6x106 ab 
(3.9)  
1.9x106ab 
(7.4)  
20 µg/L 3.7x107 bc 
(3.8) 
3.5x106 ab 
(4.0)  
1.5x106bc 
(4.9)  
50 µg/L 3.7x107 bc 
(1.9) 
3.5x106 ab 
(2.0)  
1.1x106 c 
(12.9)  
100 µg/L 3.4x107 c 
(2.1) 
3.3x106 b 
(2.2)  
1.0x106 c 
(9.6)  
Each value of bacterial load is a mean of duplicate assays using the standard plate count method. The 
samples were incubated at 37°C. Pre-incubation bacterial load was 4.6 x 109 CFU/mL. Values in brackets 
are coefficient of variation in percentage. Values in individual columns with different letters are 
statistically different (p < 0.05). All the controls were significantly different from their respective 
treatments. 
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Table B10: Viability of L. bulgaricus in various concentrations of T-2 and in control 
L. bulgaricus 
T-2 
concentrations 
Bacterial load (cfu/mL) after incubation 
with T-2 
 
Control (bacterial load in 
cfu/mL after incubation 
Incubation time  24 h 48 h 72 h 24 h 48 h 72 h 
Toxin 
concentrations 
20 µg/L 4.1x108 a 
(2.2)  
3.0x107 a 
(6.4)   
1.3x106a 
(1.5)  
4.5x108 
(3.1) 
3.0x107A 
(2.4) 
2.1x106 
(3.4) 
50 µg/L 3.8x108 ab 
(2.1)  
2.9x107 ab 
(6.1)  
1.2x106 ab 
(7.4)  
100 µg/L 3.6x108 bc 
(0.0)  
2.4x107 abc 
(11.8) 
1.1x106ab 
(6.7)  
200 µg/L 3.4x108 cd 
(3.7)  
2.3x107bc 
(2.5)  
9.5x105b 
(6.1)  
250 µg/L 3.2x108 d 
(1.7)  
2.2x107bc 
(4.7)  
9.7x105b 
(5.7)  
Each value of bacterial load is a mean of duplicate assay using the standard plate count method. The 
samples were incubated at 37°C. Pre-incubation bacterial load was 4.6 x 109 CFU/mL. Values in brackets 
are coefficient of variation in percentage. Values in individual columns with different letters are 
statistically different (p < 0.05). All the controls except the ones at 48 h incubation were significantly 
different from the treated samples. 
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Appendix C 
Pictorial display of the research  
In this section, some of the key analyses that were undertaken in this research are demonstrated in 
pictorial form. The key aspects covered include: bacterial isolation process, bacterial growth curves 
using OD600 and the standard plate count method, cellcharacterization, cell cleaning and suspension in 
PBS, mixing of toxin with bacteria, incubation and toxin extraction. Finally, the toxin assay is 
demonstrated in pictorial form. 
  
Fig. C1: Isolation of LAB in the Food Microbiology Laboratory, College of Food Science and 
Technology, Guangdong Ocean University, China. 
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Fig. C2: Gram stain for Streptococcus thermophilus isolated from CY: Gram-positive and spherical-
shaped cells that occur in chains resembling a string of beads. 
  
Fig. C3: Gram stain for L. acidophilus; Gram-positive and rod-shaped cells. The cells appear singly, in 
pairs or in short chains.  
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Fig. C4: Gram stain for L. bulgaricus isolated from CY; Gram-positive and rod-shaped cells. 
  
Fig. C5: Gram stain for L. casei shirota isolated from FMD; Gram-positive, rod-shaped cells. 
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Fig. C6: Bacterial growth curve using optical density (OD) at 600 nm; five bacterial cells grown in MRS 
broth, incubated at 37°C, under anaerobic conditions.  
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Fig. C7: Bacterial growth curve using the standard plate count method (SPC); Lactobacillus casei 
shirota and Streptococcus thermophilus spread on MRS agar, incubated at 37°C, under anaerobic 
conditions; cells reported as CFU/mL. 
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Fig. C8: Centrifugal cleaning of LAB cells; cells cultured in MRS broth then cleaned with PBS; 7000 x 
g, 4°C, 5 min; Food Microbiology Laboratory; College of Food Science and Technology, Guangdong 
Ocean University, China. 
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Fig. C9: Toxin-bacteria mixture; incubated at 37°C, for 72 h; toxin extracted after incubation; Food 
Toxicology Laboratory; College of Food Science and Technology, Guangdong Ocean University, 
China. 
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Fig. C10: Cell viability count; L. bulgaricus mixed with various concentrations of AFB1; toxin-bacteria 
mixtures incubated at 37°C and spread on MRS agar after 24, 48 and 72 h; cells reported as CFU/mL. 
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Fig. C11: Sample of cell viability count; L. bulgaricus mixed with various concentrations of T-2; toxin-
bacteria mixtures incubated at 37°C and spread on MRS agar after 24, 48 and 72 h; cells reported as 
CFU/mL.  
 
